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The aim of the present series of studies was to evaluate changes in the myocardium assessed with 
single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) caused by 
coronary artery disease, examine the capability of multidetector computed tomography coronary 
angiography (MDCT-CA) to detect significant stenoses in the coronary arteries, and magnetocar-
diography (MCG) to assess remote myocardial infarctions. 
Study objectives 
Study I: The purpose was to evaluate the effect of transmyocardial laser revascularization (TMLR) 
on myocardial function and perfusion with a combination of cine MRI and thallium myocardial 
perfusion SPECT. 
Study II: We evaluated the capability of multichannel MCG to detect remote myocardial infarc-
tion.  
Study III: We evaluated the diagnostic accuracy of 8-row MDCT-CA in detecting high-grade 
(>50%) stenoses in the tree main coronary arteries in patients with coronary artery disease. We cor-
related MRI findings of the myocardium with MDCT-CA of the coronary arteries. 
Study IV: The aim of this study was to evaluate whether MDCT-CA could replace invasive CCA in 
patients with acquired severe aortic valve stenosis. 
Methods 
Study I: Eight patients with severe triple vessel CAD were studied with MRI and myocardial perfu-
sion SPECT before and six months after laser treatment. 
Study II: We evaluated the capability of multichannel MCG to detect remote myocardial infarc-
tion. Multichannel MCG over the frontal chest was recorded at rest in 21 patients with remote 
myocardial infarction , detected by MRI, and in 26 healthy controls.  
Study III: Fourteen CAD patients underwent CCA, MDCT-CA, and MRI. We determined the cal-
cium scores and stenoses of the coronary arteries from MDCT-CA.  The left ventricular MR cine 
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imaging was assessed at rest and perfusion defects were observed during pharmacological stress 
after contrast administration.  Delayed contrast-enhanced MRI was performed to picture infarctions. 
Study IV: Twenty-three patients with acquired severe aortic stenosis underwent both CCA and 
MDCT-CA.  The total and volumetric calcium scores were calculated. Image quality of each coro-
nary segment was evaluated as assessable or nonassessable for stenosis. The images of the arteries 
were evaluated for presence of artifacts and presence of high-grade stenoses (≥ 50%) by visual es-
timation and compared with that of CCA. 
Results 
Study I: TMLR did not improve global left ventricular (LV) function or myocardial perfusion. 
However, systolic wall thickening decreased in segments with fixed perfusion defects at six months 
and laser treatment prevented this decrease (p=0.03). In addition, SPECT imaging indicated that 
TMLR prevented conversion of reversible defects into fixed defects. 
Study II: MCG repolarization indexes, such as ST-segment and STT-wave integrals, separated the 
MI group from the controls. The abnormalities were more distinct in the Q-wave-MI than in the 
non-Q-wave MI subgroup. When comparing the MI group with controls, the orientation of the 
magnetic field maps differed in the STT-wave maps. 
Study III: MDCT-CA had a sensitivity of 82%, a specificity of 94%, a positive predictive value of 
79%, and a negative predictive value of 95% for stenoses over 50% in the main coronary arteries as 
compared with CCA. LV wall dysfunction, perfusion defects, and infarctions were detected in 50-
78% of sectors assigned to calcifications or stenoses, but also in sectors supplied by normally per-
fused coronary arteries. 
Study IV: A total of 224 out of 322 segments were assessable for stenosis. MDCT-CA had a sensi-
tivity of 63%, a specificity of 96%, a positive predictive value of 52%, and a negative predictive 






Conventional invasive coronary angiography (CCA) is the clinical gold standard for detecting of 
coronary artery stenoses. However, the small risk of serious events, the discomfort for the patient, 
and the hospitalization required have led to a search for noninvasive methods. The ability to differ-
entiate between viable and nonviable myocardium plays a critical role in the prognosis of patients 
with coronary artery disease (CAD) (42, 106, 143, 149). Until recently, single photon emission to-
mography (SPECT) and positron emission tomography (PET) were the primary tools for this 
evaluation (162). 
Magnetic resonance imaging (MRI) and computed tomography (CT) imaging are emerging as 
promising complementary imaging modalities in the primary diagnosis of CAD and in the detection 
of subclinical atherosclerotic disease. For the detection or exclusion of significant CAD, both car-
diac CT (including coronary calcium screening and noninvasive coronary angiography), and cardiac 
MRI (using stress function and perfusion imaging) are becoming widely available for routine clini-
cal evaluation. The high negative predictive value, especially when combining two or more of these 
modalities, allows the exclusion of significant CAD with high certainty, provided that patients are 
selected appropriately. The advantage of multidetector computed tomography (MDCT) are the po-
tentially complete assessment of the entire coronary artery tree within a very short scan time, and 
with combined MRI the excellent soft tissue contrast.  For the diagnosis of obstructive coronary 
atherosclerosis and for screening, CT has shown potential in directly imaging the atherosclerotic 
lesion, measuring the atherosclerotic burden, and characterizing the plaque components (89, 90, 
108, 169). The information obtained may be used to assess progression and regression of coronary 
atherosclerosis and may open new areas for diagnosis, prevention, and treatment of the disease. 
Further clinical investigation is needed to define the technical requirements for optimal imaging, to 
develop accurate quantitative image analysis techniques, to outline criteria for image interpretation, 
and to define the clinical indications for both MR and CT imaging. 
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Magnetocardiography (MCG) provides noninvasively information about myocardial excitation 
propagation and repolarization without the use of electrodes. This evolving technique may be con-
sidered the magnetic equivalent to electrocardiography. MCG has been used to stratify with respect 
to sudden death in patients with CAD (112) or dilated cardiomyopathy or long QT syndrome (165), 
to localize tachyarrhythmic foci in patients with CAD (65) or dilated cardiomyopathy, to map ac-
cessory pathways in patients with pre-excitation syndrome (113), to reveal fetal arrhytmias (186), 




3. REVIEW OF THE LITERATURE 
 
3.1. Coronary artery disease (CAD) 
3.1.1 Pathophysiology of acute ischemia 
The coronary artery is vulnerable to atherosclerosis, which is the main cause of ischemic heart dis-
ease. Angina is caused by coronary artery atherosclerosis leading to luminal stenosis. In the early 
and clinically unapparent stage of atherosclerosis, smooth muscle cells are invading the intima and, 
by the apoptosis of macrophages, lipid is depositing in the intima layer of the coronary artery and is 
commonly associated with endothelia dysfunction. 
The biomechanical stability of atherosclerotic lesions in coronary arteries is determined by their 
composition. The typical advanced atherosclerotic lesion is characterized by a core of extracellular 
lipid with an overlying fibrous collagen-rich cap (139). Lipid pools in human atherosclerotic lesions 
dramatically increase intimal wall shear stress compared with fibrous tissue and calcifications (69), 
rendering lipid-rich atherosclerotic plaques by far more unstable and vulnerable to sudden rupture 
than other types of lesions (14). Disruption of the fibrous cap of the atheroma in coronary arteries 
with consecutive thrombosis, and vessel occlusion is a common cause of myocardial infarction (MI) 
(139).  
Advanced disease consists of multiple stenotic lesions varying degrees of severity, leading to a 
chronic or acute reduction of coronary perfusion. It is now recognized that accumulation of athero-
sclerotic plaque in the coronary arteries begins much earlier than the development of luminal nar-
rowing, with acute coronary syndromes often precipitated by the sudden rupture of a previously 
nonsignificant stenosed plaque (184). 
Although coronary artery calcification is associated with worse cardiovascular prognosis, the influ-
ence of calcification on biomechanical plaque stresses is unclear (164). However, it is possible that 
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the stiff calcification is a marker for the extent of disease or for another process such as inflamma-
tion or infection (69). 
 
 
Trombotic occlusion of an epicardial coronary artery is usually the cause of acute MI.  Within 10 
seconds after occlusion of a coronary artery, the myocardium initiates anaerobic glycolysis with 
accumulation of lactate and other metabolites (19, 153).  If the duration of coronary occlusion is 
extended beyond 20 min, a wavefront of necrosis marches from subendocardium over mid-
myocardium to subepicardium over time (86). Mechanisms of muscle necrosis in irreversible 
ischemic myocyte injury are loss of cell membrane integrity and of intracellular-extracellular ion 
homeostasis, resulting in swelling of the infarcted cells. Microvascular endothelial damage leads to 
increased leakage of macromolecules into the interstitium of the injured territory. This combined 
with the liberation of intracellular proteins increases the osmolarity in the interstitium and leads to 
interstitial edema (46). “No-reflow” is possible if capillaries have been occluded by extravascular 
compression, endothelial swelling, and intravascular elements such as platelet aggregates (150). The 
course of myocardial necrosis will be completed in 6 h (150, 153).  
3.1.2 Hibernation, stunning, and scar formation 
During ischemia, a large portion of the area at risk undergoes biochemical and pathological changes 
associated with anoxia, but remains potentially viable. At reperfusion, the potentially viable cells 
may reverse the changes occurring during ischemia and recover normal function or progress to ne-
crosis (110).  
The infarct-associated region often shows impaired contractile function. Three mechanisms may be 
responsible for this: chronic scar formation, stunning, and hibernation (19, 86, 87).  
The recovery of contractile function following an acute ischemic event may be delayed for some 
time despite the restoration of adequate blood flow (perfusion-contraction mismatch). This condi-
tion is called stunning (19). A stunned myocardium usually recovers spontaneously after reperfu-
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sion, but myocardial dysfunction may be present for several days although coronary blood flow is 
normal (17). The mechanism of stunning involves generation of oxygen radicals, alteration in cal-
cium homeostasis, and a contracted protein structure (86, 87).  
Hibernation describes a condition of persistently impaired myocardial function at rest caused by 
chronic hypoperfusion (20). After revascularization, which re-establishes adequate perfusion and 
oxygen supply, the hibernating myocardium is capable of regaining normal contractile function.  
Whereas a stunned myocardium shows minimal microscopic change, a hibernating myocardium has 
a pattern reminiscent of degenerating cardiomyocytes, with large perinuclear pools of glycogen and 
mitochondria and the presence of myofilaments limited to the cell periphery. This loss of myofila-
ments probably contributes to the hibernating phenomenon (86, 87, 162).  
Contractile failure of hibernation is described as being chronic stunning caused by multiple epi-
sodes of severe ischemia. This leads to an increase in oxygen demand, such as exercise, or a reduc-
tion of flow, as in coronary spasm, each followed by the equivalent of reperfusion. The result is a 
persistent stunned, acontractile state arising from downregulation of metabolism or chronic stun-
ning. In these cases, arterial flow must be improved with a revascularization procedure (87). 
The time course of stunning is acute or subacute, in the order of hours to weeks, depending on the 
degree and duration of the ischemic insult. Once the duration of ischemia is extended beyond 20 
minutes and cell death begins to occur in the subendocardium, recovery of function may require 
days or perhaps even longer. In contrast, hibernating myocardium results from months or years of 
ischemia and ventricular dysfunction. Thus, hibernation represents a chronic phenomenon (86, 87).  
3.1.3 Imaging of CAD 
3.1.3.1 Detection of lumen narrowing 
Angina is caused by coronary artery atherosclerosis leading to luminal stenosis. Invasive conven-
tional coronary angiography (CCA) is accepted reference standard for the assessment of coronary 
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artery stenoses because of its unprecedented temporal and spatial resolution and the ability to per-
form therapeutic interventions in the same session. Angiography depicts intricate coronary cross-
sectional anatomy from a planar two-dimensional silhouette of the contrast-filled vessel lumen. 
However, both necropsy studies and intravascular ultrasonography demonstrate that coronary le-
sions are often complex, with markedly distorted or eccentric luminal shapes. The traditional 
method for characterizing angiographic lesion severity relies on measurement of the percent steno-
sis. This process requires comparison of dimensions within both the lesion and an adjacent, unin-
volved “normal” reference segment. In the presence of diffuse disease, calculation of the an-
giographic percent stenosis will be predictably underestimate disease severity (184). 
Current multidetector computed tomography (MDCT) scanners provide promising results in the 
assessment of CAD, but some segments are not evaluative because of motion artifacts or severe 
wall calcification. CT reliably detects arterial calcification and allows quantification. Importantly, 
the presence of calcium within the coronary arteries almost always signifies atherosclerosis. A 
negative CT indicates that the presence of atherosclerotic plaque, including unstable plaque, is 
unlikely (13, 14, 21, 51, 66). CT provides a high diagnostic accuracy in assessing coronary artery 
stenosis (3, 88-90, 98, 109, 130). Coronary intravascular ultrasound provides valuable insights into 
the mechanisms underlying the dissociation between angiographic and clinical outcomes (184). 
However, intravascular ultrasound is an invasive and expensive way to characterize plaque. MDCT-
CA has the advantage of demonstrating the vessel wall atherosclerotic plaque (91, 108).  
3.1.3.2  Stress testing 
 
Patients with CAD usually have sufficient blood flow at rest, however, during stress, which induces 
a fourfold to fivefold increase in blood flow in healthy persons, the myocardium supplied by the 
stenotic coronary artery does not receive enough blood because blood flow is impeded through the 
narrowed coronary artery lumen.  Thus, except in very severe cases, in which the patients have 
ischemia at rest, stress testing is required to induce ischemia. 
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The ergometric stress measure is the most physiologic stress test, but images with any modality 
may be hard to acquire because of motion. Pharmacologic stress measurement is preferred by many 
clinicians because the results are highly reproducible and diagnostic in most patients (127).  
Dobutamine has positive inotropic and chronotropic effects, both of which increase myocardial 
oxygen requirements. During low-dose infusion (5-10 µg/min) increased myocardial contractility is 
the major effect. At higher dosages, the increased consumption of oxygen causes contraction ab-
normalities in myocardial segments supplied by stenotic coronary arteries (127). Dobutamine en-
hances regional contractility, increases heart rate, and decreases the systolic vascular resistance 
leading to ischemia in areas supplied by stenotic coronary arteries. The majority of experience using 
the dobutamine stress test has accumulated in conjunction with echocardiography (172).  Stress is 
induced by increasing doses of dobutamine, started at 10 ug/kg of body weight per minute for 3 min 
and increased in increments of 10 ug/kg of body weight per minute every 3 min until a maximal 
dose of 40 ug/kg of body weight per minute is reached (100). Dobutamine is particularly useful for 
inducing wall motion abnormalities (127).  
Dipyridamole, its metabolic product, and the active component adenosine are vasodilators. Incre-
mental doses of dipyridamole causes increasing vasodilatation and relative hypoperfusion in areas 
supplied by significantly diseased vessels (83). Vasodilators are the preferred stressors for perfusion 
and flow measurements. Dipyridamole (0.56 mg/kg) is infused over a period of 4 minutes during 
continuous monitoring of one ECG lead and blood pressure (107). The effect of adenosine is almost 
instaneous, where as the reaction for dipyridamole takes minutes to reach its peak. A typical dose of 
short-acting adenosine is 140 µg/minute for maximum of 6 min (127). 
3.1.3.3 Left ventricular (LV) function 
LV functional status is well recognized as a predictor of future cardiac events after myocardial in-
farction. Blood flow during systole is a measure of global myocardial contractility, but it is influ-
enced by afterload. Afterload is the resistance against which a ventricle contracts. Contractility de-
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scribes the force of myocardial fiber contraction. Cardiac function is proportional to the product of 
contractility and preload and inversely proportional to the afterload (53).  
Ejection fraction (EF) is a global assessment of LV performance (33). EF as well as LV volumes 
are important clinical variables with respect to diagnosis, management, and prognosis of patients 
with cardiac diseases. The stroke volume, the difference between end-diastolic and end-systolic 
volumes, increases with increasing end-diastolic volume if the afterload remains constant. The EF 
correlates contractility with volume measurements and is calculated by the formula EF= (EDV-
ESV)/EDV, where EDV is the end-diastolic volume and ESV the end-systolic volume. The normal 
EF for the LV is greater than or equal to 0.55. The gold standard for measurement of ventricular 
volumes has been to apply Simpson´s rule to short axis cine MR images and summarized by the 
equation: V=£ΣA (S+G), where V is the chamber volume, A the area of the lumen of the slice, S the 
slice section thickness, G the gap thickness, and n the number of slices to encompass the ventricle 
(53). 
 Several techniques have been used for determination of LV volumes and EF; among these echo-
cardiography, cineventriculography, radionuclide-ventriculography, and MRI (64). 
As an imaging modality, echocardiography has the advantage of being widely available for assess-
ment of LV. It provides an efficient semiquantitative assessment of global cardiac function (8). Nu-
clear cardiology is said to provide an accurate assessment of LV function with good reproducibility 
using gated myocardial perfusion SPECT (175). This technique is frequently utilized when a 
SPECT perfusion scan is performed and adds prognostic value (160). However, the exposure to 
ionizing radiation is unsuitable when repeated measurements are required. Cardiac MRI has been 
shown to be an accurate and reproducible tool for the estimation of LV volumes and function (8).  
 
Of particular interest in patients with ischemic heart disease is the assessment of regional LV func-
tion. This can be easily estimated by visualization of short-axis cine sequences of the LV. LV short-
 18
 
axis sections are divided into six sectors from the interventricular groove in a clockwise fashion 
according to the standards suggested by the American Society of Echocardiography and the AHA. 
A proposal for a unitary method of division into 17 segments has been made that requires the analy-
sis of three equidistant transverse short-axis planes and longitudinal plane of the LV (23). Each 
segment is assigned to a specific coronary artery; however, depending on the coronary artery anat-





 Figure 1. 
Left ventricular (LV) short axis segments suggested by American Heart Association. 
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3.1.3.4 Detection of perfusion defects  
Impaired blood flow through a stenosed coronary artery results in reduced perfusion and corre-
spondingly diminished myocardial oxygen delivery.  Initially, hypoperfusion is seen in the suben-
docardial portion of the cardiac muscle. As blood flow is further reduced, the perfusion deficit be-
comes transmural, so that first diastolic and then systolic myocardial function become impaired 
(174). 
To detect significant stenoses of the epicardial coronary arteries, it is helpful to stress the patient so 
that a measure of the coronary flow reserve or similar measures (127). Under pharmacological 
stress, the stenotic vessel is unable to respond like a healthy vessel because of its higher vascular 
resistance, which results in a vascular steal phenomenon with increased blood flow to the territories 
supplied by the nonstenotic vessels. Thus, a perfusion defect appears in the perfused myocardial 
territory served by the stenotic vessel. Other possible causes of microvascular obstruction include 
myocardial edema and endothelial cell damage from free radical formation and endothelial dysfunc-
tion (15, 150, 196).  
Stress myocardial perfusion SPECT has been widely used for demonstrating altered regional myo-
cardial perfusion in patients with CAD. Perfusion-metabolism mismatch- that is, preserved metabo-
lism in an area of decreased perfusion- is considered as the gold standard for myocardial viability 
assessment (142).  However, the method suffers from attenuation artifacts and exposes patients to 
radiation. PET imaging corrects for attenuation and allows for the quantification of perfusion, but it 
is not widely available (60, 99).  
Dynamic MRI with a bolus injection of contrast material enables assessment of first-pass myocar-
dial enhancement during pharmacologic stress, which can provide information regarding the pres-
ence and extent of CAD.  Myocardial territory affected by a coronary lesion may or may not exhibit 
a perfusion deficit during first-pass imaging under resting conditions. Hypoenhancement during 
first-pass is caused by reduced blood flow (194). This can be due to a severely stenosed, already at 
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rest hypoperfused coronary artery, or to impaired microvascular blood flow in infarcted regions 
(162). Hypo-enhancement at rest during first-pass is a sign of nonviability (163). Underperfused 
regions of the myocardium in resting studies correlate with increased amounts of nonviable tissue. 
Lesser stenoses can prove undetectable at rest (35).  
In recent studies stress perfusion MRI showed a sensitivity of 87-90% and specificity of approxi-
mately 85% when coronary angiography was used as a gold standard (73, 171). In addition, the en-
hancement at dynamic MRI during stress correlated more closely with CCA results than stress 
SPECT findings in patients without myocardial infarction (73). 
3.1.4 Interventional treatment strategies 
The basic technique of percutaneous transluminar angioplasty (PTA) involves passing of guide-wire 
and catheter across stenosis or through an occlusion in a blood vessel. A balloon catheter is then 
positioned across the diseased segment and dilated up to the same size as the adjacent lumen, in 
order to increase the blood flow through the artery or vein (181). 
Mechanical rotation devices are used to recanalize complete occlusions, where conventional cathe-
ter and guide-wire combinations have failed (198). Atheroma-removing devices are also used to 
recanalize complete occlusion (184). 
Intravascular stents are used to maintain the lumen of a vessel by a mechanical supporting effect of 
its wall. The indications for their use are to prevent an acute occlusion developing after an intimal 
flap has been produced by angioplasty, to abolish the pressure gradient across a significant residual 
stenosis after angioplasty, and to treat recurrent stenoses and following recanalization of an artery 
(181). 
Fibrinolytic therapy has been used in the treatment of various thrombotic diseases, such as acute 
myocardial infarction. A tip of the catheter is placed in the acute occlusion to deliver intra-arterial 
infusion of a low dose streptokinase into the thrombus (181). 
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Transmyocardial laser revascularization (TMLR) is a technique in which laser ablation creates 
transmural channels in the ischemic myocardium. This procedure is used as the sole therapy for 
patients with severe angina refractory to medical therapy or not amenable to new conventional by-
pass procedures (134). 
Three different types of lasers are used. The high power carbon dioxide (CO2) laser is creating the 
laser channel by a single shot and Holmium: Yttrium-Aluminium-Garnet (YAG) and Excimer lasers 
are creating the channels with multiple impulses of lower power guided in a fibreoptic into the 
myocardium (34).  
The procedure is based on the premise that laser-created transmural channels allow blood to flow 
directly from the left ventricle to myocardial vascular plexus, thus allevating ischemia in potentially 
viable myocardium (4). 
 
3.2 Multidetector computed tomography (MDCT) 
 
MDCT represents the next breakthrough in computed tomography (CT) technology. 
Multislice CT systems are equipped with four or more parallel detector arrays and always utilize a 
third-generation technology with synchronously rotating tube and detector array. Scanning is done 
by proper collimation and summing the signals of neighboring detector rows. As in spiral CT scan-
ning, section collimation (SC), table feed per rotation (TF), and pitch (P) are the most important 
acquisition parameters in multislice CT. In addition to the reconstruction increment (RI), an effec-
tive section thickness or section width (SW) of reconstructed images contributes to the most impor-
tant reconstruction parameters.  All other parameters are varied only in exceptional cases (148).  
Advantages of MDCT compared with single detector-row CT are shorter scan duration, longer scan 
ranges, and thinner sections. The downside of multislice CT is that image noise grows as the section 
collimation (SC) is reduced. To limit the noise, either the radiation dose needs to be raised or 
 22
 
thicker sections must be reconstructed. Radiation dose is substantially increased in MDCT if the 
same mAs settings as in single-slice scanning are used, but conscientious choice of scanning pa-
rameters will avoid this problem (148). 
3.2.1 Assessment of coronary arteries with MDCT  
A new generation with subsecond rotation MDCT scanners that allow complete coronary coverage, 
has become widely available.  
Cardiac MDCT imaging can be done using two basic modes of operation for image acquisition: 
prospective triggering and retrospective gating (135). For sequential imaging, a prospective trigger 
is derived from the ECG trace to initiate the CT scan with user selected delay after the R-wave. For 
spiral imaging, the ECG trace and the CT data are recorded simultaneously. Retrospective gating 
can be then used to select the spiral data for image reconstruction relative to a selected heart phase 
(85). When images are obtained in the diastolic cardiac phase motion artifacts are minimized, even 
in patients with faster heart rates (135). 
3.2.1.2 Coronary calcium assessment 
Calcified deposits within the coronary arteries have been shown to be an independent predictor of 
CAD. At present, coronary calcium scoring is in widespread use for risk stratification. Ultrafast CT 
has previously been demonstrated to be a sensitive detector of coronary artery calcium (30). 
A method for semiquantative assessment of the amount of coronary calcium based on electron-
beam CT findings has been introduced by Agatston et al. (5). The calcium score derived with this 
method appears to correlate closely with the overall atherosclerotic coronary plaque burden (192). 
With this algorithm, two or more contiguous pixels with attenuation of 130 HU or greater in the 
suspected location of an epicardial artery are considered indicative of a calcified lesion. Lesions 
with peak attenuation of 130-200 HU are assigned a value of 1, 201-300 HU a value of 2, those 
with 301-400 HU a value of 3, those with value greater than 400 HU a value of 4. The integer value 
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of the area of each lesion is multiplied by a lesion-specific calcium score (5). However, some analy-
ses have revealed that this traditional scoring method is not suited for accurate and reproducible 
determination of the amount of coronary calcium for clinical purposes (189). This method is based 
on the multiplication of the area of calcified plaque by an arbitrary coefficient that is derived from 
peak plaque attenuation. For this reason, a volumetric method, based on the principle of isotropic 
interpolation, that allows more precise and reproducible measurements of calcified plaque volume 
was developed by Callister et al. In this method, all voxels with a value greater than 130 are used in 
the final three-dimensional reconstruction of the calcified plaque (21, 66).  
CT is probably the most sensitive and reproducible imaging method to quantify coronary calcifica-
tions. Even the tiniest calcification will be visible by reconstruction with a soft tissue kernel. In 
general, a coronary calcium scan is acquired in a single breath hold with 3-mm ECG-triggered 
slices of the heart. Retrospective ECG gating is superior for capturing the entire volume and recon-
struct the images with overlapping increment (135). After the acquisition, the data are post proc-
essed by a dedicated workstation.  
3.2.1.3 Plaque imaging 
In the process of atherogenesis, lipid accumulation, cell proliferation, and extracellular matrix syn-
thesis are expected to be linear over time. However, angiographic studies show that the progression 
of CAD in humans is neither linear nor predictable. Indeed, recently, it has become apparent that 
angiographically mild coronary lesions may undergo significant progression to severe stenosis or 
total occlusion within a few months. This unpredictable and episodic progression is likely caused by 
plaque disruption with subsequent thrombus formation that changes the plaque geometry, leading to 
plaque growth and acute occlusive coronary syndromes (192).  
It is widely accepted that only one-third of myocardial infarctions directly arise from significant 




The differentiation of coronary plaque morphology has gained interest with respect to risk stratifica-
tion of patients with known or suspected CAD (39).  The current gold standard for in vivo coronary 
tissue analysis is intracoronary ultrasound, which is an invasive procedure (91, 108).  
Preliminary data indicate that MDCT angiography allows detection and assessment of noncalcified 
lipid-rich plaques (89, 90, 108, 169). Low density plaques (40 HU) may consist of a larger fraction 
of lipid than high-density plaques (90 HU), which predominantly contain fibrous tissue (14). 
3.2.1.4 Detection of stenoses 
Invasive CCA constitutes the clinical gold standard for detection of coronary artery stenoses. 
MDCT in combination with retrospective ECG gating has recently been shown to permit visualiza-
tion of the coronary artery lumen and detection of coronary artery stenoses. In other studies, sensi-
tivity of 37-93%, specificity of 89-99%, positive predictive value of 66-84%, and negative predic-
tive value of 89-98 % have been reported performed with 4- or 16-slice techniques (49, 89, 90, 92, 
93, 98, 104, 130, 131, 156, 185).  Initial results of  two groups suggest that 64-slice CT allows a 
nonivasive assessment of haemodynamically significant CAD with even higher diagnostic accu-
racy. The overall sensitivity was 94% and 99%, the specificity was 97% and 95%, the positive pre-
dictive value was 87% and 76% and the negative predictive value was in both studies 99% (109, 
122).  
There are several limitations of MDCT-CA. The presence of extensive calcifications can complicate 
correct assessment of the lumen of the coronary arteries. High-contrast calcium depositions cannot 
be sufficiently isolated from the contrast-enhanced vessel lumen, leading to nonassessable segments 
or misinterpretations (49, 89, 90, 92, 93, 98, 130). A heart rate of over 65 beats per minute has 
yielded unsatisfactory results in a few studies (90, 98, 170). 
Although manual repositioning of the R-wave indicators during retrograde gating improves the syn-
chronization of acquisition intervals between consecutive heart beats, cardiac motion artifacts can-
not be entirely prevented. Movement of the patient, such as breathing, also causes motion artifacts, 
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which can be reduced by appropriate instruction before scanning (130).  Blending with overlying 
vessels can lead to false-positive interpretations (116, 131). In addition, small vessel size renders 
evaluation of stenoses more difficult (195). 
 
3.3 Magnetic resonance imaging (MRI) 
 
The use of MRI for cardiac diagnosis is expanding, aided by the administration of paramagnetic 
contrast agents for a growing number of clinical applications. 
MR imaging is an excellent means to depict cardiac anatomy. In general, contrast agents are not 
required for morphologic evaluation. In evaluation of LV function cine images show the motion of 
the heart and blood over multiple phases of the cardiac cycle (35). Myocardial regional blood flow 
can be assessed using dynamic MRI during the first-pass of a contrast agent. The ability to differen-
tiate between viable and nonviable myocardium plays a critical role in the prognosis of patients 
with coronary artery disease. Delayed enhancement MRI technique can be used to identify irre-
versible myocardial damage in both the acute and chronic settings (33). One of the advantages of 
MRI in cardiovascular diagnosis is its ability to measure flow velocity and flow volume (103). MRI 
of the coronary arteries is potentially useful in a variety of clinical situations such as congenital 
coronary artery anomalies, determination of the patency of bypass grafts, and follow-up of known 
proximal coronary lesions (35).  
The challenge in cardiac MRI is to cope with the motion of the heart due to ventricular contraction 
and the superimposed respiratory movement during the time needed for imaging. Breath-hold imag-
ing is the approach used most widely to avoid respiratory-related displacement of the heart. MRI 
systems also incorporate respiratory-sensing devices to reduce the number of artifacts resulting 
from chest wall motion (138). Electrocardiography (ECG)-gating synchronizes cardiac imaging at 
pre-selected intervals during the cardiac cycle. Data are collected in gates or time windows at inter-
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vals synchronized with the ECG to produce gated images throughout the phases of the cardiac cycle 
(53).  
In retrospective ECG gating, image data are acquired irrespective of the ECG, and the ECG is re-
corded in parallel. Once the MRI acquisition is finished, the computer retrospectively calculates the 
appropriate cardiac phases based on the stored ECG and k-space data. The entire cardiac cycle can 
be imaged efficiently (40). Retrospective gating was developed for synchronization of rapid repeti-
tive cine acquisition to the cardiac cycle (103). 
 In prospective triggering, the image acquisition starts immediately after the R-peak of the ECG 
complex which is the initiation of systole. The duration of image acquisition must be less than or 
equal to the duration of the shortest R-R interval. In practice, this usually means that the last data 
from  10-20 % of diastole is not acquired (103). 
3.3.1 MRI sequences 
3.3.1.1 Spin echo (SE) 
In cardiac MRI SE sequence is particularly useful for evaluating cardiac structure, paracardiac and 
intracardiac masses and thrombi, and acute and remote myocardial infarctions (146). 
With the SE technique, an initial excitation pulse at resonance (90° radio frequency pulse) is ap-
plied to tilt the spins around the axis of the excitatory magnetic field. Longitudinal magnetization is 
reduced and transverse magnetization is generated, but starts to disappear rapidly because of spin 
dephasing. After a time period of half of echo time (TE), a refocusing pulse (180° RF pulse) is ap-
plied, and after another one half of TE an echo is produced (146). The combination of selected time 
of repetition (TR) and TE determines whether images have T1- or T2-weighting. T1-weighted SE 
images are acquired with a combination of short TR and short TE (154). The images obtained with 
shorter echo times have a better signal-to-noise ratio and excellent contrast among epicardial fat, 
myocardium, and rapidly flowing blood. The absence of signal from flowing blood (flow void or 
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dark blood) is also a feature of the SE sequence (146). T2-weighted SE images are acquired with a 
combination of long TR and long TE (154).  
Faster turbo spin echo (TSE) has replaced conventional SE imaging. TSE uses a long train of 180° 
refocusing pulses to generate multiple spin echoes after an initial 90° excitation.  Each echo in the 
train is phase-encoded to generate a different line in k-space (146). The possible reduction in meas-
urement time is directly proportional to the number of echoes used (154). Although the technique is 
much faster than conventional SE, disadvantage is the poorer soft tissue contrast (146).  
3.3.1.2 Gradient echo (GRE) based sequences 
The white-blood sequences are widely being used at present for assessment of the LV, including the 
measurement of dimensions and wall thickness, and the calculation of functional parameters (54). 
The basic GRE technique uses a single radio frequency pulse to produce an echo signal. Following 
excitation by the RF pulse, a magnetic field gradients are used to focus the protons to produce a 
coherent MR signal. This signal is called a gradient echo, and the process that produces it can occur 
very quickly (1-10 ms). Typically gradient echoes are obtained at TE of 2-8 ms, and this can be 
repeated approximately every 10-20 ms (146).  Blood appears bright compared with the to adjacent 
myocardium due to time-of-flight effects as well as the relatively long T2 (33).  
 
A new approach to improve cine imaging involves a technique known as steady-state free preces-
sion pulse (SSFP) sequence e.g. trueFISP (= fast imaging with steady state precession), balanced 
FFE (=fast field echo), and FIESTA (=fast imaging employing steady-state acquisition) (33).  In 
SSFP sequences, both the transverse and the longitudinal magnetizations attain steady-state while 
TR is kept shorter than T2. When TR is much less than T2, the transverse magnetization can be 
detected over many TR time-in-time intervals (199). TrueFISP is a steady-state technique that recy-
cles coherent transverse magnetization, and the steady state signal is determined by the T2-to-T1-
signal ratio (22).  Because blood has significantly higher T2-to-T1 ratio than the myocardium and 
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because trueFISP uses the available blood signal very efficiently, trueFISP differentiates the blood, 
myocardium, and epicardial fat exceptionally well (199). On the other hand, trueFISP is quite sensi-
tive to magnetic field nonuniformity caused by, for instance, metallic objects such as sternal wires. 
In addition, cancellation artifacts are frequently seen as dark etched outlines at the major interfaces 
between fat and water (144).  
Recently, the saturation recovery (SR) true fast imaging with a SSFP sequence proved to give supe-
rior image quality, since it makes the most efficient use of the available magnetization (168). The 
SR prepared sequence comprises a magnetization preparation period consisting of a nonselective 
90º pulse, followed by a gradient crusher gradient and a subsequent short TR/short TE (22). The 
saturation technique in cardiac MRI is used to maximize the T1 contrast between a normal and a 
hypoperfused myocardium during a dynamic contrast-enhanced first-pass acquisition of the myo-
cardium. Because of good T1 contrast between a normal and a hypoperfused myocardium, this 
technique is well suited for first-pass imaging (179). 
 
TR can be shortened to several milliseconds with GRE techniques such as fast-low angle shot 
(FLASH), which uses a very short flip angle and TR (56, 154). A turboFLASH sequence consists of 
a single 180º inversion recovery (IR) preparation followed by rapid gradient echo acquisition (110). 
This sequence produces strongly T1-weighted images owing to use of the inversion pulse before 
image acquisition (177). IR pulse sequence consists of a 180º inversion pulse followed by either a 
SE, GRE, or echo planar imaging (EPI) sequence. After the inversion pulse, the magnetization re-
covers exponentially from the maximal negative value to a maximal positive value through the T1 
null point. Inversion pulse can also be applied to null fat.  The time interval between the inversion 
pulse and the excitation pulse is known as time of inversion (TI) (174).  
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The TI is then defined as the time between this 180º pulse and the center of acquisition of the seg-
mented k-space lines. The TI is chosen such that the magnetization of the normal myocardium is 
near its zero crossing to ensure that these regions appear as dark as possible (79). 
The IR technique in cardiac MR is used for characterization of tissue after administration of con-
trast media. The signal of the normal-perfused myocardium is suppressed to better visualize hyper-
intense areas due to contrast uptake. One can distinguish perfused tissue in the endocardial and 
epicardial layers of the myocardium (179).  
3.3.2 Contrast media 
Two classes of MR contrast agents have been used for myocardial imaging. Paramagnetic agents 
are used in a dose range that causes shortening of T1 and hence higher signal intensity (SI) in the 
area to which they are distributed. The effect of these T1-enhancing agents can be observed in T1-
weighted SE, GRE, and EPI. The second group, magnetic susceptibility agents, induce local varia-
tions in the tissue magnetic field, thereby causing a decrease in SI. This effect can be in T2-
weighted SE, T2* sensitive GRE, and EPI (159).   
Based of their mechanisms of distribution contrast agents are classified as extracellular, intravascu-
lar, targeted, or intracellular agents. The molecular weight is a major factor in the distribution and 
elimination of MR contrast agents in the body (18). 
Widely used gadolinium (Gd) has the greatest influence on the relaxation times of proton nuclei. 
This is due to the presence of seven unpaired electrons with the long electron T1 times, which are 
important for proton relaxation. Extracellular agents are distributed rapidly into both the intravascu-
lar and extracellular spaces, typically with a plasma half-life on the order of 20 min. Most Gd-
chelates, including gadopentetate dimeglumine, gadodiamide, gadoteridol, and gadoversetamide, 
belong to this category (35).   
Extracellular Gd-chelates enhance the blood and normal myocardium in a homogenous fashion. 
Peak enhancement is achieved within 1 min of intravenous injection of these agents. Extracellular 
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agents diffuse out of capillaries into the interstitium but do not enter the intracellular space of viable 
tissue (159). Rupture of the cellular membrane, which signifies the death of a cell, allows Gd-
chelate to enter the cell, and its tissue concentration at equilibrium is increased proportionally (191).  
Extracellular contrast agents are widely used outside of the heart, for a large number of clinical ap-
plications. In the heart, they are used mainly for the evaluation of myocardial viability and for char-
acterization of masses (35).  
3.3.3 MRI of the ischemic myocardium 
3.3.3.1 Wall motion abnormalities 
The ability of cine MR to visualize global and regional wall motion and systolic thickening of the 
LV with a high degree of spatial and temporal resolution makes it an excellent method to detect 
abnormalities in contractility. Except for high-grade coronary artery stenosis, abnormalities can 
typically only be identified under stress conditions.  Stress can be induced with infusions of phar-
macologic agents such as dobutamine/atropine, dipyridamole, or adenosine (127).  
Echocardiographic detection of wall motion abnormalities during high-dose dobutamine or exercise 
stress has been shown to be an accurate diagnostic tool for screening patients with suspected CAD. 
However, dobutamine stress echocardiography has inherent disadvantages.  Even with the most 
advanced machines, 10-15% of patients yield suboptimal or nondiagnostic images. Mainly basal 
and lateral and inferior segments show poor endocardial delineation. Accuracy largely depends on 
the experience of diagnostic centers and observers, and test reproducibility is low (63). Dobutamine 
cardiovascular MRI is used to identify wall motion abnormalities of the left ventricle, indicative of 
myocardial ischemia in patients with proven or suspected CAD (100, 101). Analysis of viability can 
be done qualitatively by visual analysis of wall motion at rest and during infusion of low-dose 
dobutamine or by measuring wall thickness and wall thickening (106, 107, 127, 155). Segmental 
wall motion is graded as normokinesia, hypokinesia, akinesia, or dyskinesia (127). A minimal end-
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diastolic wall thickness of more than 5 mm with resting thickening or resting akinesis and an im-
provement in systolic wall thickening of 2 mm or more during dobutamine stimulation are clinically 
diagnostic criteria for myocardial viability (9, 10). Myocardial wall thickening is useful for measur-
ing regional function, and it is more precise than subjective visualization of wall motion. Experi-
mental and clinical studies have shown that myocardial dysfunction caused by hibernation or stun-
ning, but not by scaring, can be transiently reversed by positive inotropic stimulation. During dobu-
tamine infusion, systolic wall thickness increases in viable, but not scarred, myocardium, because 
only the viable cells are able to respond to inotropic stimulus (9, 162).  
 Echocardiography and cine MR have been compared with angiography for the detection of CAD 
(128).  According to this study, with dobutamine stress MR, stress-induced wall motion abnormali-
ties were detected with a significantly higher diagnostic accuracy than with dobutamine stress echo-
cardiography in patients with suspected CAD, (sensitivity 86.2% vs. 74.3% and specificity 85.7% 
vs. 69%). Because high-dose dobutamine stress cine MRI is highly accurate and can be performed 
within less than 40 min, it has the potential to replace dobutamine stress echocardiography for the 
detection of CAD in patients with nondiagnostic or suboptimal echocardiographic image quality 
(128).  
3.3.3.2 First-pass imaging 
The development of high-speed MRI techniques has enabled assessment of relative perfusion of the 
myocardium by monitoring the first transit of a bolus of contrast agent. When a compact bolus of 
Gd contrast agent is administered intravenously, its first passage into the heart reflects delivery at 
the myocardial level. Under normal circumstances, a bright or enhanced image can be obtained in 
all regions of the myocardium. Perfusion deficits are recognized as areas of reduced SI due to either 




The results of Sakuma and colleagues showed that stress first-pass contrast-enhanced MRI provides 
the detection of significant stenosis in the coronary artery with a diagnostic accuracy comparable 
with that of stress 201T1 SPECT without attenuation correction (161). In study by Keijer et al. dur-
ing pharmacological stress, the MR perfusion parameters and slope of the SI-time curve showed 
moderate correlation with 201T1 SPECT (77). 
Changes in SI form the basis of both qualitative and quantitative methods of image analysis. Semi-
quantitative and quantitative evaluations require the definition of myocardial regions-of-interest 
(ROIs), image registration, extraction of signal intensity time-curve data, and analysis or mathe-
matical modelling of contrast agent kinetics to derive the chosen parameters (174).  
The mean signal intensity for each determined ROI is measured on consecutive images. The data 
are presented as a series of signal intensity-time curves for myocardial regions and ventricular cavi-
ties. Peak enhancement and time-to-peak enhancement are the key criteria for the identification and 
characterization of perfusion defects. Any reduction or delay in regional peak signal intensity sug-
gests hypoperfusion. This can be further categorized as reversible or fixed by a comparison of stress 
and rest studies (106).  
The absolute quantification of myocardial blood flow requires a precise estimation of the volume of 
blood entering a unit weight of myocardium per unit time (174). Although this has been modelled, 
there are many assumptions, and in practice, a semiquantitative assessment is made that examines 
the change in signal intensity over time, the gradient of the unslope, peak signal intensity, and time 
to peak. The myocardial perfusion reserve index can be quantified by the difference between myo-
cardial perfusion reserve (MPR) in stress and rest studies (28, 95, 96). 
Myocardial MR first-pass perfusion (MRFP) imaging can be applied for assessing the severity and 
extent of perfusion defects in CAD before and after interventions or for diagnostic purposes (194). 
Myocardial first-pass perfusion can predict whether myocardial function can recover after a myo-
cardial infarction and revascularization (78, 155).  Identifying inducible ischemia and the “area of 
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risk” during pharmacological stress is also possible. Another unique feature of MRFP is that suben-
docardial perfusion defects can be localised as an early sign of ischemia, particularly in a hibernat-
ing or stunned myocardium (194). 
To detect significant stenoses of the epicardial coronary arteries, it is helpful to stress the patient so 
that a measure of the coronary flow reserve or similar measures, such as the MPR index, can be 
obtained (127).  
The "no-reflow" phenomenon, which indicates lack of reperfusion from microvascular impairment 
at the core of a reperfused infarct, presents as a subendocardial region of persistent hypoenhance-
ment (78, 196). Since flow at the core is very low but not zero, the hypoenhanced regions eventually 
become hyperenhanced (33). Lauerma et al. found a significantly higher first-pass enhancement 
slope in hypokinetic myocardial sectors that responded to dobutamine stressing as compared with 
ones that did not respond and with normal sectors (106). In a study of 34 patients with a stenosis of 
an epicardial coronary artery of at least 75%, a cut-off value of 1.5 for MRI perfusion reserve helped 
differentiate normal from ischemic myocardial  segments (6).  
3.3.3.3 Late enhancement imaging 
Late enhancement MRI is performed following the intravenous administration of Gd-chelate. After 
an appropriate delay (typically 5-20 minutes), breath-hold IR-prepared, T1-weighted GRE images 
are acquired. The typical pulse sequence for myocardial late enhancement MRI is turboFLASH se-
quence. The correct choice of the appropriate inversion time (approximately 200 ms) to null the 
signal intensity of normal myocardium is important for accurate delineation of the infarcted region 
(35). The result is an image in which viable tissue is dark, and nonviable, fibrotic, or scarred tissue 
appears bright (33).  Nonviable tissue has substantial amounts of interstitial space, while viable tis-
sue has little interstitial space. The “wash-in/out” rates for Gd-chelate in nonviable tissue are re-
duced. As a result, Gd-chelate preferentially accumulates in irreversibly injured myocardium within 
minutes following contrast administration (78, 81, 151).  
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3.3.3.4 Assessment of chronic myocardial damage 
Late enhancement MRI is usually performed under rest conditions and combined with cine MRI for 
wall motion information. Results are interpreted in one of three ways: 1. as viable normal tissue 
(dark on viability images, normal wall motion), 2. as nonviable or irreversible damaged tissue 
(bright on viability images, dysfunctional on cine images), or 3. as hibernating or down-regulated 
viable tissue (dark on viability images, dysfunctional on cine images) (33). 
Several studies have shown that delayed contrast enhancement distinguishes between viable and 
nonviable regions within the myocardium at risk (42, 106, 143, 149). Regional elevations in con-
centrations of myocardial MRI contrast agents were exclusively associated with irreversible 
ischemic injury defined histologically and by regional electrolyte concentrations (151). 
In an animal study, hyperenhancement occurred in infarcted regions but was not observed in re-
gions subjected to reversible ischemic injury alone, despite the presence of myocardial stunning 
(42).  Ramani et al. found delayed hyperenhancement of Gd-DTPA contrast-enhanced MRI occured 
frequently in dysfunctional areas of the LV in patients with stable CAD. Hyperenhancement was 
associated with nonviability by rest-redistribution T1 myocardial perfusion SPECT and dobutamine 
echocardiography, particularly regions exhibiting resting akinesis/dyskinesis. The absence of hy-
perenhancement correlated with radionuclide and echocardiographic determinations of viability, 
regardless of resting contractile function (149).  This is in agreement with Sanstede et al., who re-
ported that evidence of delayed hyperenhancement of dysfunctional myocardium may predict lack 
of mechanical improvement or nonviability, whereas the absence of hyperenhancement correlates 
with improvement of regional contractility or viability after revascularization (163).  
3.3.3.5 Assessment of acute myocardial damage  
While DE-MRI has rapidly gained acceptance in evaluating chronic ischemic disease, its role in the 
assessment of acute myocardial damage remains controversial. Different patterns of contrast en-
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hancement in the setting of acute infarction have been reported by number of investigators both 
with and without reperfusion.  
Large human infarcts, associated with prolonged obstruction of the infarct-related artery, are char-
acterized by central dark zones surrounded by hyperenhanced regions in MRI. Conversely, reper-
fused infarcts with less regional dysfunction have uniform signal hyperenhancement (111). In an 
experimental study, a group with hypoenhanced regions within the infarct center, which were pre-
sumed to represent microvascular obstruction, had significantly more frequent cardiovascular com-
plications associated with fibrous scar formation and left ventricular remodeling (196). These 
hypoenhanced areas were found to be experimentally produced “no-reflow” regions and to reflect 
myocardial microvascular obstruction (78).  
Infarct size determined by MRI also relates directly to long-term prognosis in patients with acute 
myocardial infarction (196). A few studies have shown that the amount of delayed transmural en-
hancement predicts the degree of functional recovery after acute myocardial infarction (25, 81, 
162). Extensive transmural myocardial late enhancement is highly predictive of a lack of functional 
improvement after revascularization (81). Choi et al. studied 24 patients with first acute myocardial 
infarction immediately following the acute event and then follow up. Regions of extensive en-
hancement were unlikely to recover function, while those with only mild damage recovered sub-
stantially (25).  
It is widely accepted that delayed enhancement in certain locations, and in the appropriate clinical 
setting represents infarction, but some controversy remains (31).  Contrary evidence has emerged  
that myocardial delayed enhancement in the acute postinfarct phase may cause an  overestimation of 
the amount of irreversibly damaged tissue. Some investigators have suggested based on clinical and 
experimental research that the area of hyperenhancement on late enhancement images may be larger 
than the true necrosis and may include the adjacent area of risk (84, 137). One animal study has 
revealed that accurate determination of infarct size by delayed enhancement MRI requires imaging 
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at specific times after Gd-DTPA injection but provided a more accurate estimate with. The size of 
enhanced regions overestimated infarct size early after injection and receded over time (137).  
Nonetheless, the majority of published findings indicate that myocardial delayed enhancement accu-
rately depicts the amount of nonviable myocardium. 
 
3.4 Single photon emission computed tomography (SPECT) 
 
SPECT is based on an ordinary gamma camera made to rotate around the patient. By recording the 
radioactivity at numerous angles, sectional images may be reconstructed. SPECT is a widely used 
technique, especially in cardiac and brain studies (178). 
3.4.1 Technique 
During myocardial perfusion SPECT studies, a perfusion tracer is injected. Thallium201, 99mTc-
sestamibi, and 99mTc-tetrofosmin are three routinely used myocardial perfusion imaging tracers with 
the last one being the preferred agent for SPECT studies (142). Standard myocardial perfusion 
SPECT can be gated at rest or after exercise-stress. Two types of pharmacological stress agents are 
used: coronary vasodilating agents, such as dipyridamole and adenosine, and cardiac positive ino-
tropic agents, such as dobutamine and arbutamine (152). A same- day or separate day protocol can 
be used. With 99mTc tracers, imaging is performed 30-60 min after the injection to allow clearance of 
the adjacent extracardiac activities (117). 
During a SPECT acquisition, a gamma-camera records photons at multiple projection angles around 
the subject along a 180º or 360º arc. Acquisition starts with the R wave on the ECG, which corre-
sponds to the end-diastole. One cardiac cycle, represented by the R-R interval, is divided into mul-
tiple frames of equal duration. Acquisition of 12 to 16 frames per cardiac cycle is considered satis-
factory. To achieve adequate count density in each frame, non-gated data are acquired over many 
cardiac cycles (142). 
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3.4.2 Measurement and analysis 
ECG gating of standard myocardial perfusion SPECT acquisition allows for the quantitative or 
semiquantitative assessment of the LV function simultaneously with the evaluation of LV perfu-
sion.  
LV volumes and LVEF can be obtained easily by applying commercially available software to the 
reconstructed gated dataset.  LV regional function is more commonly evaluated visually on a cine-
loop display.  Regional endocardial wall motion can be quantitated by computing the distance of a 
given point on the endocardial surface between end-diastole and end-systole. Systolic wall thick-
ness is assessed by evaluating the changes in brightness (count intensity) from the end-diastolic to 
the end-systolic frame (142).  
The left ventricle is divided into a 20-segment model for scoring on the basis of short-axis slices. A 
severity scoring system of 0 to 4 was used for each segment: 0 = normal wall motion and thicken-
ing; 1 = mild hypokinesia/reduced thickening; 3 = severe hypokinesia /reduced thickening; and 4 = 
akinesia/absent thickening (36, 50). 
The reconstructed images are oriented in the standard short axis, horizontal long axis, and vertical 
long axis for interpretation and quantification of radiotracer uptake (55). The rest and post-stress 
images are interpreted for the presence, extent, severity, and reversibility of perfusion. A 20-
segment model of LV is used for scoring perfusion defects with a 5-point scoring system for defect 
severity (0 = normal perfusion; 1 = equivocal or mildly reduced; 2 = moderate reduction; 3 = severe 
reduction; 4 = absent perfusion (16, 36). This can be done using semiquantitative visual analysis or 
quantitatively calculated as the percentage of regional uptake of radiotracer (16, 50). A segment 
with a nonreversible defect in myocardial perfusion SPECT in an area >50% of the entire segment, 





3.4.3 Indications and clinical applications 
 
SPECT is used for the assessment of the LV functional parameters and evaluation of  risk and prog-
nosis in CAD (36, 41), determination of the myocardial viability (50, 55, 161), and evaluation of the 
CAD and functional recovery after the revascularization procedure (73). 
Myocardial perfusion has been evaluated most frequently with SPECT, and excellent sensitivity of 
stress myocardial perfusion SPECT has been reported in previous studies (41, 61, 133). One well-
recognized application of SPECT is to classify a fixed perfusion defect as a soft-tissue attenuation 
(left breast, subcutaneous fat, left hemi-diaphragm) artifact or an infarct. Because an artifactual de-
fect would show normal contraction on a gated image, artifacts can be differentiated from a true 
infarct (142).  
Persistent LV dysfunction on poststress SPECT predicts a high-grade coronary stenosis (36). The 
magnitude of the poststress regional or global dysfunction correlates also with the severity of the 
ischemia. For detection of stunning in gated SPECT, LV regional dysfunction is probably more 
sensitive than global dysfunction (141). Stress induced reversible regional wall motion abnormali-
ties on a single-day exercise Tc-99m-sestamibi-gated cardiac SPECT is highly specific for severe 
angiographic stenosis (36). MRI has become a genuine competitor of nuclear imaging in the evalua-
tion of myocardial perfusion. The results of Sakuma and colleagues showed that stress first-pass 
contrast-enhanced MRI provides the detection of significant stenosis in the coronary artery with a 
diagnostic accuracy comparable with that of stress 201T1 SPECT without attenuation correction 
(161). Recent studies have expanded the potential application of gated SPECT in the assessment of 
viability (50, 55). LV functional status can be compared before and after the revascularization pro-
cedure, the excellent reproducibility and repeatability of gated SPECT is a benefit of this method 
(142). Stress induced reversible regional wall motion abnormalities on a single-day exercise Tc-




3.5 Magnetocardiography (MCG) 
 
Detection of new ischemic episodes in patients who have undergone a previous MI remains a diag-
nostic and monitoring challenge due to distortion of the baseline ECG. 
MCG is a novel, noninvasive mapping technique to record cardiac magnetic field, generated by the 
same bioelectric currents as ECG. Interestingly, MCG is less affected by attenuation due to the in-
tervening thoracic tissue than is the electric field (176). Recent developments in the MCG instru-
mentation have enabled MCG recordings to be made in the hospital environment (57, 129).  
MCG has morphological features similar to the P-wave, QRS complex, and T- and U waves of 
ECG, and the temporal relationships between these parameters are generally the same. Almost all 
MCG studies are based on measurement of the magnetic field component perpendicular (radial z-
component) to the anterior chest. MCG is thus most sensitive to currents tangential to the chest sur-
face, whereas especially chest leads of ECG are more sensitive to radial currents. MCG may there-
fore show pathological deviation from the normal direction of depolarization and repolarization in a 
different manner than ECG. MCG is also less affected than ECG by conductivity variations caused 
by the lungs, pericardial effusion, muscles, and skin (176).  In MCG, no problems with skin-
electrode contact, common in ECG, exist (26).  
3.5.1 Clinical applications 
MCG is used in ischemia research, but also in some clinical indications. For detection of LV hyper-
trophy or dilatation from echocardiographic measurements, the sensitivity and specificity of MCG 
are similar or slightly better than standard ECG, or slightly better (45). The MCG technique is help-
ful in screening patients at risk of ventricular arrhythmias after myocardial infarction (94, 114).  
Noninvasive MCG mapping may significantly contribute to the invasive catheter mapping for opti-
 40
 
mal preoperative localization or preexcitation site and atrioventricular accessory pathways in Wolff-
Parkinson-White syndrome (113). 
MCG permits localization of tachycardia points of origin with high spatial accuracy (124). 
This technique has proven to be accurate in three-dimensional localization of magnetic pacing 
catheter in the heart (145). MCG offers a noninvasive method in the identification and classification 
of clinically relevant fetal arrhythmia and an aid in decisions concerning treatment (186).  
3.5.2 MCG rest studies in MI patients 
The largest differences between post-MI patients and controls have occurred in MCG during repo-
larization. The repolarization changes in MCG have been prominent in patients with inferior rather 
than than those with anterior Q-wave MI (105). In a study by Tsukada et al. the ratio of the maxi-
mum repolarization and depolarization values, found by compression between ST-T and QRS isoin-
tegral maxima, was reduced in patients with CAD as compared with values in healthy controls. The 
spatial evaluation of QT dispersion at rest has separated patients with CAD but without MI from 
healthy controls (187). 
3.5.3 MCG stress studies in MI patients 
MCG can be applied as an alternative to ECG during stress. In exercise stress studies ischemic ST 
depression appeared in MCG and the ST amplitude shift/R amplitude ratio was grater in MCG than 
in ECG (157). Cohen et al. found TQ baseline elevation and ST depression after a two-step exercise 
test in a patient with CAD (26). Heart-rate adjustment of the rotation of the magnetic field has im-
proved ischemia detection during the recovery phase of a bicycle exercise test (182). Hailer et al. 
have studied CAD patients during pharmalogical stress (arbutamine) and at rest. The evaluation of 
spatial distribution of QT dispersion in MCG, reflecting regional heterogeneity of repolarization, 
enhanced the sensitivity of detection of CAD both at rest and during stress compared with QT dis-
persion assessed in 12-lead ECG (58). The presence and location of acute transient ischemia can be 
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detected in exercise magnetocardiography.  The MCG method seems to be especially sensitive to 







4. AIMS OF THE STUDY 
 
The purpose of Studies I-IV was to examine noninvasive methods, single photon emission tomo-
graphy (SPECT), magnetocardiography (MCG), magnetic resonance imaging (MRI), and multide-
tector computed tomography coronary angiography (MDCT-CA) to detect changes in the myocar-
dium and coronary arteries in patients with coronary artery disease (CAD). 
 
The purpose of Study I was to detect the effect of transmyocardial laser revascularization (TMLR) 
on left ventricular (LV) wall thickness and systolic wall thickening with cine MRI  and myocardial 
perfusion with thallium SPECT. 
 
In Study II, we evaluated the electrophysiological abnormalities produced by remote myocardial 
infarction (MI) in MCG mapping and applied cine-and contrast-enhanced  MRI as a reference 
method.  
 
The aim of Study III was to evaluate the diagnostic accuracy in detecting high-grade (>50%) 
stenoses in the main coronary arteries with MDCT-CA in patients with CAD recently diagnosed 
conventional coronary angiography (CCA). A further aim was to correlate the results of MRI tech-
niques - resting cine, stress first-pass, and late enhancement imaging with results of MDCT-CA at 
regional level. We studied how calcifications and fibrous/fatty stenoses in the coronary artery lumen 
detected with MDCT-CA can predict regional LV dysfunction and perfusion changes in the myo-
cardium evaluated with MRI. 
 
The aim of Study IV was to evaluate whether MDCT-CA could be used to exclude clinically sig-




5. MATERIALS AND METHODS 
 
 
All study protocols were approved by the local ethics committee. All patients gave written informed 
consent after the procedure had been fully disclosed to them.  
 
5.1 Subjects 
This study consisted of 43 patients with coronary artery disease, 23 patients with aortic valve steno-
sis, and  26 healthy controls. 
5.1.1 Wall motion and perfusion analysis of transmyocardial laser revascularization (TMLR) (Study 
I) 
Eight patients with triple vessel CAD, documented in coronary angiography, were studied with 
MRI and myocardial perfusion SPECT before and six months after laser treatment.  
The mean age of the patients was 64 (range 57-72) years. All patients belonged to group III or IV 
according to the New York Heart Association (NYHA) functional classification. Patients were 
symptomatic despite adequate medical management, and they were not candidates for new percuta-
neous transluminal coronary angioplasty or coronary artery bypass grafting. Patients in this study 
had severe and diffuse CAD but did not have a target vessel suitable for grafting. All patients had 
undergone multiple redo procedures with poor results. 
All patients were treated with TMRL. This procedure is used as the sole therapy for patients with 




5.1.2 Magnetocardiography (MCG) assessment of healed myocardial infarction (Study II) 
The study population (n=47) consisted of two groups. The myocardial infarction group (n=21) in-
cluded patients with a history of one or more remote MIs and angiographically verified triple-vessel 
CAD (MI group). None of the patients had unstable CAD, and they all were symptom-free at the 
time of the MCG recording.  
The control subjects (n=26) were healthy middle-aged volunteers with no coronary risk factors and 
no history or signs of cardiovascular disease. They had normal symptom-limited bicycle exercise 
test results without angina or ST segment changes and a normal ECG. 
5.1.3 Noninvasive analysis of coronary artery disease with combination of MDCT and functional 
MRI (Study III) 
A total of 14 patients with coronary artery disease diagnosed with CCA underwent MDCT-CA and 
MRI between February 2003 and August 2003. CCA was performed 4-6 weeks prior to MDCT-CA 
and MRI. The time interval between CT and MRI study was 1-7 days.   
Inclusion criteria were angiographically diagnosed CAD and no contraindications to CT or MRI 
examinations. Patients with previous coronary artery bypass surgery and unstable clinical condition 
were excluded from the study.  Exclusion criteria for CT were renal insufficiency, heart failure, and 
arrhythmia. Contraindications to MRI were claustrophobia and metal implants (clips in the brain, a 
pacemaker, or other metal objects). 
 Three patients belonged to group I, nine to group II, and two to group III according to the NYHA 
functional classification. Nine patients had one affected vessel and five had two affected vessels. 
One patient underwent balloon angioplasty and stenting before MDCT-CA and MRI. The mean age 




5.1.4 Eight-row multidetector computed tomography coronary angiography evaluation of signifi-
cant coronary artery disease in patients with severe aortic valve stenosis (Study IV) 
Twenty-three patients undergoing cardiac catheterization because of severe aortic valve stenosis 
(AS) were studied. They constituted having severe AS with or without clinical suspicion of CAD. 
Thirteen patients suffered from dyspnea, 11 from angina, and 2 had a history of syncope. Exclusion 
criteria included renal insufficiency, heart failure, and unstable clinical condition. 
The mean age was 71±10 years (range 46-85) years, thirteen men and ten women.  
 
5.2 SPECT imaging protocol (Study I) 
 
Multislice diagrams gated SPECT thallium201 myocardial perfusion studies were obtained from all 
patients before and 6 months after laser revascularization with Elscint Apex 425 ECT equipment. 
Imaging was acquired by 180° rotation, using SPECT single-head system and starting 5 min after 
injection of 74 MBq (2 mCi) thallium201 chloride at peak exercise. The redistribution images were 
obtained 3 h later.  Thirty views were acquired by 180° rotation at 6° intervals for 20 minutes with a 
single-head low-energy all-purpose collimator (Elscint APC-3). Reinjection images were obtained 
24 h later after a dose of 56 MBq (1.5 mCi) thallium. Routine uniformity and radius-of-rotation 
checks were performed. A 64 x 64 matrix with pixel size of 0.6 x 0.6 cm and slice thickness of 0.6 
cm was used. 
An exercise stress test was performed together with myocardial perfusion. The patients underwent 
symptom-limited bicycle stress testing in which the exercise load was increased every 4 min. 
Maximum exercise time, workload (Watts), stage duration, heart rate, and blood pressure, and rea-




5.3 MCG (Study II) 
 
A 67-channel magnetometer was used (Neuromag Ltd., Helsinki, Finland) for MCG recordings, 
which were performed in a magnetically shielded room (Euroshield Ltd., Eura, Finland) of the 
BioMag Laboratory in a hospital environment. The sensors, 7 co-axial and 60 planar dc-SQUID 
(Superconducting Quantum Interference Device) gradiometers, record the spatial change in the 
magnetic field component perpendicular to the measurement plane. The cardiometers are ar-
ranged on a slightly curved surface with a diameter of  30 cm and immersed in liquid helium in-
side a dewar.  The dewar is supported by a gantry, allowing easy adjustment of the sensor array 
both in a horizontal and vertical direction and also tilting. During the measurement, the patient is 
lying on a magnetic bed. The center of the cardiomagnitometer sensor array is placed 15 cm 
down from the jugular notch and 5 cm to the left of midsternal line, as close to the chest as possi-
ble without touching the patient. All recordings were band-pass filtered to 0.03-300 Hz and digi-
tized with a sampling frequency of 1000 Hz. 
Multichannel MCG, covering a circular area of a diameter of  30 cm over the precordium, was 
recorded for 5 min. The signals were selectively averaged and processed to obtain MCG data of 








MCG recording locations. 
A) Sensor arrangement and positioning of the cardiomagnetometer with 33 recording locations 
in relation to the thorax. The device was placed anteriorly, with the center of the device 15 cm 
caudally from the jugular notch and 5 cm left of the midsternal line. B) In the magnetic field map 
(MFM), the location and orientation of the steepest spatial change in the signal, the peak gradi-
ent, is indicated by an arrow. Solid lines indicate positive values and magnetic flux toward the 
chest, and dotted lines indicate negative values and flux out of the chest. Orientation of the mag-
netic field was measured as the angle between the  direction of the peak gradient and the hori-




5.4 MRI protocol (Studies I-III) 
5.4.1 Cine imaging (Studies I-III) 
Patients were positioned supine on the table of a 1.5-T imager (Magnetom Vision or Magnetom 
Sonata; Siemens, Erlangen, Germany), and imaging was performed with a body array coil as a re-
ceiver. Transverse, oblique sagittal, and double-oblique LV long-axis scout images were obtained to 
determine the final short-axis imaging plane. For LV wall motion assessment cine MR imaging was 
performed at rest with retrospectively ECG-gated segmented trueFISP pulse sequence. 
In Studies I and III, four or five short-axis sections of 10 mm thickness 15 mm apart were registered 
with a electrocardiographically gated cine MRI, which produces a series of LV wall images within 
the cardiac cycle every 40 ms. 
In Study I, the following imaging parameters were used: matrix 256 x 256, TR 80.0 ms, TE 6.1 ms 
and Flip angle (FA) 20º. In Study III, the imaging parameters were: matrix 256 X 256, field of view  
240 X 340 mm, section thickness 6 mm, FA 52º, TR 3.0 ms, and TE 1.6 ms. 
5.4.2 First-pass imaging (Study III) 
An 18-gauge catheter was inserted into the antecubital vein for dipyridamole (Persantin; Boehringer 
Ingelheim, Helsinki, Finland) infusion and gadopentetate dimeglumine (Magnevist; Schering, Hel-
sinki, Finland). Persantin was infused intravenously at a dose of 0.56 mg/kg over a 4-min period 
before contrast agent administration. Magnevist (0.05 mmol/kg) was injected intravenously at a rate 
of 5 ml/s. To view the perfusion defect, stress-induced first-pass images using a saturation prepared 
turboFLASH sequence were acquired in the four LV short-axis planes after dipyridamole infusion 
and during contrast agent injection. The following imaging parameters were used: matrix 256 X 
256, field of view 240 X 340 mm, section thickness 6 mm, TR 183, and TE 0.99. 
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5.4.3 Late enhancement (Studies II and III) 
For myocardial infarct imaging the late enhancement images were obtained 5-15 min after first-pass 
imaging using IR turboFLASH pulse sequence.  
The following imaging parameters were used: matrix 256 X 256, field of view 240 X 340 mm, sec-
tion thickness 6 mm, TR 750 ms, and TE 4.3 ms. 
Time of inversion (TI) was determined from a single post-contrast slice, where the signal in normal 
perfused myocardium was optimally suppressed (dark) to visualize hyperintense areas due to con-
trast uptake. TI for late enhancement sequence was 250-300 ms. 
 
5.5 MDCT imaging protocol (Studies III and IV) 
 
MDCT was performed with an ECG-gated 8-slice scanner (GE Medical Systems LightSpeed Ultra, 
Milwaukee, WI, USA). Patients were examined in the supine position. A native, retrospectively 
ECG-gated scan was performed to determine the total calcium burden of the coronary tree. To im-
age coronary arteries the scan delay was determined as the interval from the start of the test bolus 
(20ml) to the peak enhancement in the ascending aorta. A scan delay plus 8 seconds was kept be-
tween the initiation of the contrast agent injection and the start of the acquisition. A bolus of 120 ml 
nonionic contrast agent (Ultravist 370 mlI/ml; Schering, Helsinki, Finland) was injected through an 
18-gauge catheter into the antecubital vein at a rate of 4 ml/sec. 
The following scanning protocol was used for calcium scoring: 8 x 2.5 mm collimation, table feed 
1.5 mm/rotation, effective tube current 300 mA at 120 kV, effective slice with 3.0 mm, reconstruc-
tion increment 1.5 mm. For coronary angiography parameters were 8 x 1.25 mm, table feed 1.5 
mm/rotation, the tube current for coronary angiography was 270 mA at 140 kV, effective slice with 
1.25 mm, reconstruction increment 0.6 mm.  Patients with heart rate >65 beats per minute received 
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5 ml β-blocker intravenously (metoprolol 1 mg/ml; Leiras, Helsinki, Finland). The mean average 
radiation exposure per patient was 15.3 mSv. 
All MDCT-CA datasets were reconstructed with retrospective gating at at 20%, 40%, 60%, 70%, 
and 80% relative to the cardiac cycle. The retrospective reconstructions and ECG tracing were 
transferred to a separate workstation (GE Advantage 4.0) for analysis with a software program 
(cardIQ).  
 
5.6 SPECT image analysis 
 
Images were reconstructed by a minicomputer (Apex F1, Elscint) from the early-systolic and late- 
diastolic phases of the gated frames. Three LV short-axis sections were selected to correlate the LV 
short-axis MR sections by determining their distance from the apex on LV long-axis MRIs and 
stacks of scintigraphy sections. Circumferential profiles of myocardial thallium uptake were gener-
ated by plotting transmural mean pixel intensity against the location of each 3° radius. The profiles 
were normalized to the maximum pixel intensity, and radial intensity of less than 75% of the maxi-
mum was classified as reduced perfusion. The sections were divided into septal, anterior, lateral, 
and inferior segments, as in MRI. The septal and inferior segments were not treated with TMLR; 
lateral and anterior segments were treated.  
The segments were classified to normal tissue, reversible perfusion defect (ischemic myocardium) 
and fixed perfusion defect (scar) according to regional intensity as follows: normal; intensity >75% 
at stress and at reinjection; reversible; intensity ≤75% at stress and  >75% at reinjection; fixed; in-
tensity ≤75% at stress and at reinjection. Findings were interpreted by two observers in consensus, 




5.7 MCG image analysis 
The time instants of QRS onset, QRS offset, and T-wave offset in each location were determined 
automatically. Medians of all signals were calculated for QRS onset, QRS offset, and T-wave 
offset times and applied to define the time instants for measuring the amplitudes and the start and 
the end of the integrals in all channels. From the signal-averaged MCG data, the following inde-
ces were calculated (Figure 3).  
 
Integrals 
QRS integral: In all channels, the QRS integral was calculated as the time integral from the QRS 
onset to QRS offset.  
QRS sextiles: In all channels, the QRS integral was divided into 6 temporally equal time integral 
segments, referred as QRS sextiles.  
QRS area: In all channels, the QRS area was calculated as the sum of the absolute values of Q-, R-, 
and S-wave areas.  
ST-segment integral: In each channel, the ST-segment integral was obtained as the time integral 
from QRS offset to the midpoint between QRS offset and T-wave offset. The absolute value of the 
ST-segment integral was used to assess the QRS-ST discordance. 
T-wave integral: In each channel, the T-wave integral was obtained as the time integral from the 
midpoint between QRS offset and T-wave offset to the T-wave offset. The absolute value of the T-
wave integral was used to assess the QRS-T discordance. 
STT-wave integral: In each channel, the STT-wave integral was obtained as the time integral from 
QRS offset to the T-wave offset. The absolute value of the STT-wave integral was used to assess 
the QRS-STT discordance.  
QRS-STT discordance: To combine data of both ventricular de- and repolarization, the absolute 
value of the ST-segment integral (QRS-ST discordance), T-wave integral (QRS-T discordance), and 
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STT-wave integral (QRS-STT discordance) was subtracted from the QRS area. In channels where 
QRS integrals and ST, T-wave and STT-wave integrals were of opposite polarity, the latter were 
considered negative as used previously. 
 
Amplitudes 
ST-segment amplitude: In each channel, ST-segment amplitude was measured 60 ms after the J 
point.  
T-wave amplitude: In each channel, T-wave amplitude was the amplitude with maximum absolute 
value from the QRS offset to the T-wave offset.  
 
Optimal recording locations 
To identify the recording locations with the best discriminative power for MI detection, we used 
departure maps. In each channel and for each index, departure map values were calculated by sub-
tracting mean value of the control group from the mean value of the MI group. The obtained differ-
ence was then divided by the SD of the control group. The larger the absolute departure map value, 
the better is the performance of that channel in separating the MI group from the controls.  
 
 
Magnetic field map orientation 
Mean magnetic field maps (MFMs) of the QRS complex and the STT wave were formed by calcu-
lating the mean of the MCG signal over the mapped area. The MFMs illustrate the spatial distribu-
tion of the MCG signal over the mapped area as isofield contours. Orientations of the MFMs were 
determined by use of the surface gradient method, described in detail earlier. First, the location of 
the steepest spatial change of the signal in the MFM was found. Then, the MFM orientation was 
defined as the direction of the steepest signal amplitude change at that location.  
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QRS angle and STT angle: The orientations were determined, in degrees, for the QRS complex 
(QRS angle) and for the STT wave (STT angle).  
QRS-STT angle difference: The QRS-STT angle difference, in degrees, was calculated as the dif-






Illustration of the calculation of QRS, ST-segment, T-wave, and STT-wave integrals and QRS-
STT discordance in each MCG channel.  The QRS integral was calculated as the time integral 
from QRS onset to QRS offset.  TheQRS area was calculated as the sum of absolute values of Q-, 
R- and S-wave areas. The ST-segment, T-wave, and STT-wave integrals were obtained as the 
corresponding time integrals. a) If the main QRS deflection and the STT-wave were of same po-
larity, the STT-wave integral was subtracted from the QRS area when calculating the QRS-STT 
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discordance. The QRS-ST discordance and QRS-T discordance were calculated in an analogous 
manner. b) If the main QRS deflection and the STT-wave were of opposite polarity, the latter was 
multiplied by –1 when calculating the QRS-STT discordance. The QRS-ST discordance and QRS-
T discordance were calculated in an analogous manner. 
 
5.8 MRI analysis 
5.8.1 Global and regional LV function 
In Study I, LV diastolic and systolic volumes were assessed according to Simpson´s rule. LV vol-
umes were measured at diastole and systole by multiplying the contour areas by the slice thickness. 
Slice volumes were summed to yield the total cavity volume at diastole and systole. The end-
diastolic volume was obtained from the first image of the cine sequence. End-systolic volume was 
measured in the phase showing the smallest volume. 
 
In Study I, quantitative end-diastolic wall thickness and systolic wall thickening were assessed from 
short-axis cine MR images before and after TMLR. Three short-axis sections at the mitral tendon, 
papillary muscle, and apex level were divided into four segments: septal, anterior, lateral, and infe-
rior. Diastolic wall thickness for each segment was measured from the first image of the cine se-
quence; and systolic wall thickness from the image with the smallest LV chamber volume. Systolic 
wall thickening was calculated from these values.  Interpretation was performed by two observers 
that were blinded from the myocardial perfusion SPECT results. 
 
In Study II, when the diastolic wall thickness was less than 5.5 mm, there was less than 2 mm of 
systolic thickening, or there was significant late enhancement of more than two standard deviations 




In Study III, the four LV short-axis sections were divided into six 60° sectors from the interven-
tricular groove in a clockwise fashion. These sectors were analyzed for regional LV wall motion at 
rest by visual estimation. Findings were interpreted by two observers in consensus, with both being 
blinded to CCA and MDCT findings. On cine images, segmental wall motion was graded as nor-
mokinesia or dyskinesia. 
5.8.2 First-pass imaging 
Findings of first-pass images were visually graded as normal or perfusion defect in the myocar-
dium. Findings were interpreted by two observers in consensus, with both being blinded to CCA 
and MDCT findings.  The myocardium perfused with gadopentate dimeglumine will show an in-
crease in signal intensity because of predominant T1 shortening. Less enhanced regions of the myo-
cardium were considered  having a perfusion defect (Study III). 
5.8.3 Late enhancement 
On late enhancement images, the infarction scar with a larger interstitial space and a higher contrast 
agent concentration than healthy myocardium will have a higher signal intensity. The sectors were 
graded as normal or infarction by visual estimation. Findings were interpreted by two observers in 
consensus (Studies II and III). 
 
5.9 MDCT Image analysis 
5.9.1 Calcium scoring 
The calcium score was determined on a workstation based on two different scoring systems. All 
areas of calcification within the borders of the coronary artery and with a minimum attenuation of 
130 HU were analyzed. The total calcium score (TCS, Agatston) and the calcium volumetric score 
(CVS) were calculated for each individual plaque and for each patient by software program (Smart-
core GE) (Studies III-IV). 
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5.9.2 Detection of stenoses 
Depending on the individual coronary anatomy and image quality different visualization techniques 
such as multi-planar reconstruction, maximum intensity projections, and volume rendering tech-
niques were used to analyse stenoses in the coronary arteries. 
Fifteen datasets were produced during the different phases of the cardiac cycle (at 70% and at 20% 
to 80% in increments of 20%) for each patient. We chose the best-optimized time-window for each 
coronary artery which contained the fewest artifacts.  The images of the arteries were evaluated for 
occurrence of artefacts and presence of high-grade stenoses by visual estimation. Findings were 
interpreted by two observers in consensus, with both being blinded to CCA findings. The main 
coronary arteries were divided into three segments; proximal (A), middle (B), and distal (C) accord-
ing to the guidelines of the American Heart Association (Figure 4). In Study III side branches were 
excluded in the analysis. 
 
Figure 4. 
American Heart Association coronary segments modified. 
Left main (LM)/left anterior descending artery (LAD), left circumflex artery (LCX), and right coro-
nary artery (RCA) were divided into three segments: proximal (A), middle (B), and distal (C).  




Image quality of each coronary segment was evaluated as assessable or nonassessable for stenosis. 
Results were documented separately for the four major arteries: left main (LM), left anterior de-
scending (LAD), left circumflex artery (LCX), and right coronary artery (RCA). Diagonal branches 
of LAD and the marginal branch of LCX were evaluated separately. Causes for invisibility were 
classified as follows: 1) motion artifact (caused by heart beating or breathing), 2) adjacent structure 
(vein, contrast filled ventricle/atrium or pace maker), 3) massive calcium (calcium score > 1000 for 
a single artery), and 4) small vascular diameter (vessel diameter <1.8 mm) (Study IV). 
Coronary artery segments were classified as significantly stenosed (diameter reduction ≥50%) or 
normal by visual estimation. Each vessel was analysed on at least two plane. The datasets were ana-
lyzed in consensus by two different radiologists who were blinded to the results of CCA and MRI. 
MDCT results were compared with conventional coronary angiographic findings regarding location 
and degree of coronary artery stenoses (Studies III-IV). 
In addition, in Study III, stenotic lesions were evaluated according to density. Density under 130 
HU was categorized as soft plaque containing lipid or fibrotic material, and density over 130 HU as 
a calcified lesion. 
 
5.10 Combined data analysis 
 
Sectors 1 and 6 were assigned to LAD, sectors 2 and 3 to LCX, and sectors 4 and 5 to RCA (Figure 
5). 
We combined regional MDCT-CA findings with those of MRI.  We compared calcified and fibrous 
or fatty calcified coronary artery stenoses detected with MDCT-CA to LV wall motion at rest, per-
fusion defects during stress, and myocardial infarctions seen with MRI. We analyzed how calcifica-
tions and stenoses in the main coronary arteries predicted regional LV dysfunction, affected perfu-
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sion in the myocardium, and correlated with infarction scar in the territory of the calcified and/or 
stenosed vessel. Calcium depositions in each artery were estimated as significant or not significant. 
In addition, the total calcium burden of the coronary tree and stenoses was calculated as described 










Diagram illustrating which regions of the left ventricular (LV) myocardium are assigned to the 





5.11 Reference methods 
 
Conventional coronary angiography  
Cardiac catheterization and contrast-enhanced x-ray coronary angiography were performed accord-
ing to standard protocols.  The images were interpreted by experienced angiographers. The level 
and degree of stenoses in the main branches of the coronary arteries were visually estimated, and 
reduction in coronary artery diameter of more than 50% was considered significant. (Study II and 
IV) 
 
5.12 Statistical analysis 
 
Comparison of LV diastolic volume, ejection fraction, cardiac output, regional diastolic wall thick-
ness and systolic wall thickening between pre- and postoperative values was performed with paired 
t-tests. A significance level of p<0.05 was used (Study I). 
 
Statistical data analysis was performed with SPSS version 11.5 software (SPSS, Inc., Chicago, IL, 
USA). All continuous data are presented as mean ± standard deviation. The significance of the dif-
ference between the groups was determined with the Mann-Whitney U-test. A two-tailed p-value ≤ 
0.05 was considered statistically significant. Receiver-operating characteristic (ROC) curves were 
created to assess the performance of the parameters in the optimal channels. The results are given as 
the area under the ROC curve (AUC%) (Study II). 
 
Variables were presented as mean ± standard deviation. The sensitivity, specificity, and diagnostic 




Comparison with stenoses and LV motion / myocardial perfusion in corresponding sectors were 
performed using Fischer´s exact test, and percentages were calculated in the cross tabulation report. 







6.1 Effects of TMLR (Study I) 
TMLR did not improve global LV function in our patients. Mean diastolic volumes before treat-
ment were 158±37 ml and after treatment 166±61 ml (p=0.622) (Figure 6). There was no significant 
improvement occurred EF; mean value was 53±12% before TMLR and 50±17% after the procedure 
(p=0.376). Mean cardiac output, which was 4.19±0.88 l/min before and 4.33±0.37 l/min after the 








Figure 6.  
Mean diastolic wall thickness and systolic wall thickening in treated (lateral and anterior) and  
untreated (septal and inferior) segments before and six months after transmyocardial laser revascu-
larization (TMLR). Diastolic wall thickness in normally perfused treated segments* decreased sig-
nifically after treatment (p=0.01).  Systolic wall thickening remained unchanged in treated seg-
ments with fixed defects after the procedure but it decreased in untreated fixed defects* (p=0.03). 
 
Systolic wall thickening increased in treated segments with reversible and fixed perfusion defects, 
although the change was not statistically significant. In untreated segments with reversible and fixed 
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defects, systolic wall thickening decreased. In segments with fixed defects, this decrease was statis-
tically significant (p=0.03). We found no improvement of myocardial perfusion assessed by thal-
lium perfusion SPECT (Figure 7).  
 
 
Figure 7.  
Myocardial perfusion in thallium perfusion SPECT in treated (anterior and lateral) and untreated 
(septal and inferior) segments before and six months after transmyocardial laser revascularization 
(TMLR). Sections were divided into three groups (normal tissue, reversible defect, and fixed defect) 
on the basis of perfusion at stress and at reinjection. In the normal group, segmental intensity was 
>75% at stress and at reinjection, in the reversible defect group intensity was ≤75% at stress and 
>75% at reinjection, in the fixed defect group intensity was ≤75% at stress and at reinjection. 
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Without treatment 3/9 segments with reversible defects turned into segments with fixed defects with 
six months. On the other hand, only one of the 20 treated reversible defects turned into a fixed de-
fect according to thallium SPECT. Laser treatment did not prevent the change from a normal to an 
ischemic segment. 
In the thallium exercise scan 5/8 patients had a greater tolerance of workload  (p=0.125) and 6/8 
had longer exercise times at maximum workload (p=0.396) six months after TMLR. The test was 
stopped less frequently for angina symptoms after TMLR (5/8 patients) (Figure 8).   
 
Figure 8. 
 Workload tolerance and exercise times in the thallium exercise scan before and six months after 
TMLR. Of the eight patients, five had a greater tolerance of workload and six had longer exercise 




Postoperatively improvement in the NYHA functional class was obvious; before the procedure, 3/8 
patients belonged to group III, 4/8 to group III-IV, and 1/8 to group IV. Six months after TMRL, 
five patients belonged to class II, two to class II-III, and one to class III. 
 
6.2 Myocardial infarctions in MRI and MCG (Study II) 
 
Of the 21 MI patients, 11 had MI in only one anatomic region: 1 patient solely anterior, 1 patient 
solely apical, 3 patients solely lateral, and 5 patients solely inferoposterior MI. The remaining 10 
MI patients had multiple MIs in more than one anatomic region. By assigning patients into more 
than one infarction location subgroup, altogether 9 patients had anterior MI, 10 patients apical MI, 4 
patients lateral MI, and 13 patients inferoposterior MI. 
 
Sums of MCG parameters over the mapping region 
Depolarization abnormalities in remote MI 
QRS area: The QRS area was larger in the MI group than in the controls (MI group 15 ± 5.7 pTs vs. 
controls 11 ± 3.7 pTs; p<0.042). The QRS area also separated the QMI subgroup but not the NQMI 
subgroup from the controls (QMI subgroup 16 ± 6.7 pTs; p<0.044 compared to the controls). 
QRS integral: The QRS integral failed to separate the MI groups from the controls. The individual 
QRS sextiles were not more informative than the whole QRS integral. 
Repolarization abnormalities in remote MI 
ST-segment integral: The ST-segment integral did not separate the MI group or the NQMI subgroup 
from the controls. In the QMI subgroup the ST-segment integral was more negative than in the con-
trols (QMI subgroup –1.5 ± 1.8 pTs, controls –0.3 ± 1.2 pTs; p=0.037). The MI group and the 
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NQMI subgroup, however, showed a trend similar to the QMI subgroup but the difference was not 
significant.  
T-wave integral: The T-wave integral did not separate any of the MI groups from the controls.  
STT-wave integral: The STT-wave integral did not separate the MI group or the NQMI group from 
the controls. The STT-wave integral was more negative in the QMI subgroup than in the controls 
(QMI subgroup –2.8 ± 4.4 pTs, controls 1.5 ± 4.7 pTs; p=0.034). A trend similar to QMI group was 
found in the MI group and in the NQMI subgroup.  
 
Depolarization and repolarization discordances 
QRS-ST discordance: The QRS-ST discordance was larger in the MI group and in the QMI sub-
group than in the controls (MI group 16 ± 6.6 pTs, QMI subgroup 17 ± 7.4 pTs, controls 11 ± 3.9 
pTs; p=0.020, AUC 70% and p = 0.009, AUC 74%, respectively). The NQMI subgroup showed a 
similar trend to the MI group and QMI subgroup but the difference was not significant.  
QRS-T discordance: The QRS-T discordance was larger in the MI group and in the QMI subgroup 
than in the controls (MI group 13 ± 8.7 pTs, QMI subgroup 15 ± 8 pTs, controls 5.9 ± 6.2 pTs; p= 
0.004, AUC 75% and p = 0.001, AUC 80%, respectively). The NQMI subgroup showed a similar 
trend to the MI group and QMI subgroup but the difference was not significant.  
QRS-STT discordance: The QRS-STT discordance was larger in the MI group and in the QMI sub-
group than in the controls (MI group 14 ± 10 pTs, QMI subgroup 17 ± 9.3 pTs, controls 5 ± 1.7 
pTs; p=0.003, AUC 76% and p=0.001, AUC 80%, respectively). The NQMI subgroup showed a 
similar trend to the MI group and QMI subgroup but the difference was not significant.  
 
Optimal recording locations 
QRS integral: The MI groups had larger positive integral values over the inferior part of the map-
ping region and smaller negative integral values over the superior part of the mapping area than the 
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controls. The QRS integral in optimal sites separated the MI group and the QMI subgroup but not 
the NQMI subgroup from the controls (AUC 71% for the MI group, 77% for the QMI subgroup).  
ST-segment amplitude: The MI groups had smaller negative values over the inferior part of the 
mapping region, and larger positive values over the superior part of the mapping area than the con-
trols. The ST-segment amplitude in the optimal sites separated all MI groups from the controls 
(AUC 85% for the MI group, 85% for the NQMI subgroup, and 90% for the QMI subgroup). 
T-wave amplitude: The MI groups had smaller negative values over the inferior part of the mapping 
region, and larger positive values over the superior part of the mapping area than the controls. The 
T-wave amplitude in the optimal sites separated all MI groups from the controls (AUC 91% for the 
MI group, 91% for the NQMI subgroup, and 92% for the QMI subgroup). 
STT-wave integral: The MI groups had smaller negative values over the inferior part of the map-
ping region, and larger positive values over the superior part of the mapping area than the controls. 
The STT-wave integral in optimal sites separated all MI groups from the controls (AUC 91% for 
the MI group, 90% for the NQMI subgroup, and 92% for the QMI subgroup). 
 
MFM orientation in MI 
The QRS angle failed to separate any of the MI groups from the controls. The STT angle was larger 
in the MI group and in the QMI subgroup than in the controls (MI group 163 ± 119°, QMI subgroup 
220 ± 110°, and controls 58 ± 17°; p=0.006 and p<0.001, respectively). The QRS-STT angle was 
not significantly different between the MI group or the NQMI subgroup and the controls. The QRS-
STT angle was larger in the QMI subgroup than in the controls (QMI subgroup 94 ± 59° and con-










Figure 9 a. 
 The group mean QRS integral and STT-wave integral magnetic field maps. From top to bottom: 
the whole myocardial infarction patient group (MI), the Q-wave myocardial infarction subgroup 
(QMI), the non-Q-wave myocardial infarction subgroup (NQMI), and the healthy controls (con-
trols). The QRS integral maps of all patient groups resemble the map of the controls. On the con-
trary to QRS maps, the STT-wave integral maps show much more variation in between all the MI 
groups and the controls. The step between two isocontour lines is 100 pTs. Positive values are 






Figure 9 b. 
QRS integral and STT-wave integral departure maps. From top to bottom: the whole myocardial 
infarction patient group (MI), the Q-wave myocardial infarction subgroup (QMI), and the non-Q-
wave myocardial infarction subgroup (NQMI). In the QRS integral departure maps, the MI groups 
had larger positive values over the inferior part and smaller negative values over the superior part 
of the mapping region than the controls. In contrast, in the STT-wave integral departure maps, the 
MI groups had larger negative values over the inferior part and larger positive values over the su-
perior part of the mapping region than the controls.  
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6.3 Assessment of coronary artery disease with MRI and MDCT (Study III) 
 
The MDCT was performed without complications in all patients. A total of 126 (14x9) coronary 
artery segments were scanned. All the segments were evaluated. The mean scanning time with 
breath hold was 24 ± 3 (range 19-30) s and the mean heart rate was 56 ± 8 (range 43-70) beats per 
minute. Ten patients had β-blocker medication and therefore a low heart rate. Four patients had a 
heart rate of over 70 beats per minute before examination, and they received a β-blocker injection 
intravenously. The mean total calcium score was 555 ± 1061 (range 0-4009), and the mean calcium 
volumetric score was 446 ± 808 (range 0-3074) (Table 1).  
 
PATIENT  TCC CVS 
1 65 85 
2 362 294 
3 852 694 
4 205 174 
5 4009 3074 
6 35 55 
7 1280 986 
8 113 125 
9 0 0 
10 3 5 
11 91 82 
12 508 432 
13 191 174 
14 54 67 







Calcium scores of all patients based on two different scoring systems, total calcium score (TCS) by 




In CCA, a stenosis over 50% was found in 28 segments; 10 in RCA, 10 in LAD, and 8 in LCX 
segments. Sixteen segments had a stenosis of less than 50%. Six stenoses of over 50% were found 
in side branches.  
In MDCT-CA, 8 lesions (>50%) were detected in RCA, 9 in LAD, and 6 in LCX segments. We 
found six soft plaques (HU< 130) in the main coronary arteries; three of those caused significant 
narrowing of the vessel (Figure 10). Significant calcifications in a single main coronary artery were 
visually detected in eight arteries. 
In MDCT-CA, two stenoses in the proximal area of RCA as well as lesion in the distal part of LAD 
were missed because of  massive calcifications. Assessment of lumen in the presence of excessive  
calcium impaired diagnostic quality since the lumen compromise could not be sufficiently  visual-
ized. 
Two LCX stenoses were missed because of patients´ irregular heart beat and/or  high heart rate 
(>65 beats per minute) and an artefact due to adjacent structure (overlying vessel or contrast-filled 
ventricle). Overestimation of stenoses and therefore false-positive lesions  in RCA (2) and LAD (4) 
segments due to severe calcifications. 
Compared with CCA, sensitivity was 82%, specificity 94%, positive predictive value 79%, and 
negative predictive value 95% for significant stenoses (Table 2). Sensitivity was 75%, specificity 
69%, positive predictive value 77%, and negative predictive value 73% when evaluation was done 
by vessel. 
A total of 336 (14x24) myocardial sectors were analyzed from MRI pictures. The myocardial sec-
tors supplied by calcified or stenotic arteries observed with MDCT-CA showed regional LV wall 
dysfunction at rest, perfusion defects at stress, and myocardial infarction on late enhancement im-
ages (Figure 11).  These changes were also detected in territories related to nonsignificantly 
stenosed and noncalcified arteries. Late enhancement was detected more often than LV wall dys-






 RCA LM/LAD LCX TOTAL 
SEGMENTS 
 
42 42 42 126 
TRUE POSITIVE 
 
8 9 6 23 
FALSE POSI-
TIVE 
2 4 0 6 
FALSE NEGA-
TIVE 
2 1 2 5 
TRUE NEGA-
TIVE 
30 28 34 92 
SENSITIVITY 
 
0.80 0.90 0.75 0.82 
SPECIFICITY 
 












Sensitivity and specificity of multidetector computed tomography coronary angiography (MDCT-
CA) compared with conventional coronary angiography (CCA). 
RCA=right coronary artery, LM=left main artery, LAD=left anterior descending artery, and 









Coronary artery stenosis detected with MDCT-CA 
A 39-year-old man with one-vessel coronary artery disease. Multiplanar multidetector  reconstruc-
tion shows that the right coronary artery has a significant (>50%) stenosis  and a soft plaque also 





Left ventricular hypokinesia, perfusion defect and infarction evaluated with MRI 
MRI short-axis views of the left ventricle of a 39-year-old patient with one-vessel coronary 
artery disease. TrueFISP cine MRI (a.diastole; b systole) in short-axis view shows hypokine-
sia of sector 5. 
In stress induced first-pass imaging (saturation recovery prepared turboFLASH sequence) 
perfusion defect is seen in the sector 5 (c). Late enhancement image (inversion recovery tur-

























































Combined results of MDCT-CA and MRI 
 
Despite the coronary artery being classified as normal in CCA, LV wall dysfunction was observed 
in 5/10, perfusion defect in 3/10, and infarction in 7/10 corresponding myocardial sectors.  
High and irregular heartbeat impaired image quality in MDCT-CA and caused misinterpretation of 
significant stenoses in two lesions. LV wall dysfunction and perfusion defect were observed in two 
sectors assigned to this artery. Because of massive calcifications, we missed three stenoses, which 
resulted in perfusion defect in 3 corresponding sectors and infarction in 2 sectors. 
In five cases, the dominant main coronary artery was found to be stenosed in MDCT-CA. In these 
patients, LV wall dysfunction was observed in 5/7, perfusion defect in 9/11, and infarction in 4/6 
sectors adjacent to the assigned sectors. 
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In CCA, stenoses under 50% were found in 16/32 segments, which were classified in MDCT-CA as 
not significantly stenosed. LV wall motion dysfunction was detected in 8/16,  perfusion defect  in 
10/16, and infarct in 4/16 sectors assigned to these arteries with stenosis less than 50%. Stenoses in 
side branches evaluated with CCA (n=6) resulted in LV wall dysfunction and perfusion defect in 
three myocardial sectors, and infarction was detected in one sector.  
In Fisher´s exact test, these combined results were not statistically significant. 
 
6.4 Eight-row MDCT evaluation of significant coronary artery disease in patients with severe aortic 
valve stenosis (Study IV) 
 
The MDCT was performed without complications in all patients. A total of 322 coronary artery 
segments were scanned.  The mean scanning time with breath hold was 22 ± 3 (range 20-29) sec-
onds. Fifty-six percent of patients received pre-scan intravenous B-blockers, resulting in a mean 
heart rate of 62 ± 8 (range 49-75) beats per minute. Two patients had a pacemaker.  
The total calcium scores (TCS) were 1068 ± 1709 (range 0-7377) and calcium volumetric scores 
(CVS) were 866 ± 1302 (range 0-5601) (Table 4). 
Overall visibility of coronary segments by MDCT-CA was 70%. Of 322 segments 224 were assess-
able for stenosis.  A total of 98 segments of coronary arteries were nonassessable because of motion 
artefacts (Figure 12), disturbing adjacent structures, massive calcium depositions (Figure 13), and 









PATIENT TCS CVS 
1 574 515 
2 25 31 
3 6 12 
4 837 791 
5 0 0 
6 899 764 
7 998 803 
8 7377 5601 
9 165 174 
10 1497 1229 
11 312 346 
12 361 304 
13 166 130 
14 268 277 
15 2029 1599 
16 343 382 
17 3711 3010 
18 739 618 
19 844 702 
20 3384 2566 
21 9 13 
22 0 0 
23 37 53 




Calcium scores. TCS=total calcium score, CVS=calcium volumetric score. 
 







LM=2 1 (50%) - 1 (50%) - 
LAD=12 3 (25%)  - 7 (58%) 2 (18%) 
LCX=26 7 (27%) 4 (15%) 12 (46%) 3 (11%) 
RCA=26 11 (42%) 4 (15%) 7 (27%) 4 (15%) 
SIDE 
BRANCHES=32 
8  (25%) 6 (19%) 10 (31%) 8 (25%) 










Motion artifacts cause discontinuity between consecutive slices and inhibit correct analysis of sig-









31 % of our patients and 50% those of with typical angina had significant CAD. In CCA, 19 
stenotic lesions were found; 5 lesions were in RCA, 2 in LM, 3 in LAD, 4 in LCX segments, and 5  
in side branches. In MDCT-CA 6 lesions were detected in RCA, 2 in LM, 9 in LAD, 3 in LCX, and 
3 in side branches (Figure 14). In MDCT-CA, 7 lesions were missed despite sufficient image qual-
ity. These included 2 stenoses in the middle area of RCA, 3 LCX stenoses, and 2 lesions in side 
branches were missed. Eleven segments were incorrectly classified as significantly obstructed be-
cause of overestimation of lesion severity, mostly as a result of massive calcifications. False- posi-










a)    b) 
 
Figure 14.  
A 48-year-old man with one-vessel coronary artery disease. Conventional coronary angiography 
(CCA) (a) and multiplanar multidetector computed tomography (MDCT) reconstruction (b) shows 
the right coronary artery with significant stenosis in the proximal part and narrowing of the lumen 
(<50%) in the distal part. MDCT shows soft plaques in the stenotic areas. 
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Concerning angiographically diagnosed CAD, for all vessels including nonvisible and nonassess-
able ones MDCT-CA showed a sensitivity of 63%, and a specificity of 96%, a positive predictive 
value of 52%, and a negative predictive value of 98% (Table 6).  For proximal vessel segments, 
sensitivity was 88%, specificity 96%, positive predictive value 70%, and negative predictive value 
99%.  With respect to correct diagnosis per patient 15 patients out of 23 (65%) were correctly diag-
nosed using MDCT. When evaluating only proximal segments, 20 (87%) patients were correctly 
diagnosed. 
 









23 69 69 69 92 322 243 92 89 
TRUE  
POSITIVE 
2 3 1 3 3 12 12 7 7 
FALSE 
POSITIVE 
0 6 2 3 0 11 11 3 3 
FALSE 
NEGATIVE 
0 0 3 2 2 7 7 1 1 
TRUE 
NEGATIVE 
21 60 63 61 87 292 213 81 78 
SENSITIVITY 
 
1.00 1.00 0.25 0.60 0.60 0.63 0.63 0.88 0.88 
SPECIFICITY 
 













Sensitivity and specificity of multidetector computed tomography coronary angiography (MDCT-







Cardiac magnetic resonance imaging continues to develop and advance. SPECT perfusion imaging 
has been considered the reference method for evaluation of nonviable myocardium, but MRI  can 
accurately depict structure, function, effusion, and myocardial viability, with an overall capacity 
unmatched by any other single imaging modality. MRI is an accepted and widely utilized tool for 
cardiovascular research, and its clinical use is also increasing (33). MCG reveals information com-
plementary to body surface ECG in patients with ischemic heart disease (71). MDCT-CA is a prom-
ising noninvasive technique for detection of coronary stenoses (121). Recently, it was demonstrated 
that detection of calcified and noncalcified plaques in the coronary arteries of patients with sus-
pected CAD is feasible MDCT (14). 
 
7.1 Assessment of coronary disease with MDCT 
 
Invasive imaging techniques, especially selective CCA, has remained vital to planning and guiding 
catheter-based and surgical treatment of significantly stenotic coronary lesions, but in selected pa-
tient groups CAD diagnosis should be obtained with a noninvasive method to prevent unnecessary 
cardiac catheterizations. Previous studies have demonstrated that both echocardiography and nu-
clear perfusion imaging, using pharmacological stress testing, are sensitive and safe methods, but 
resting or exercise-induced regional wall motion abnormalities are only nonspecific markers for 
CAD, and some studies have shown low specificity of thallium SPECT (11, 70, 136). 
Several recent studies have demonstrated that MDCT-CA allows imaging of coronary artery 
stenoses, coronary calcifications (3, 49, 89, 90, 92, 93, 98, 120, 130, 131, 156, 185), and even dif-
ferentiation of plaque morphology with high spatial and temporal resolution (90, 91, 132, 169).  
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The main objectives of Studies III and IV were to determine the accuracy of MDCT in detecting 
significant stenoses in the main coronary arteries and excluding of angiographically significant 
CAD in patients with known CAD (Study III) and in patients with AS (Study IV).  
Among patients with AS, the prevalence of CAD is 40-50% in those with typical angina, 25% in 
those with atypical chest pain, and 20% in those without chest pain (24, 38, 52, 123). In one study, 
coexisting CAD was observed even in up to 60% of patients with aortic stenosis (173). These find-
ings are in accord with ours; 31% of our AS patients and 50% of those with typical angina had sig-
nificant CAD. On the other hand, in some patients no evidence of angina pectoris was found, but 
severe calcifications, significant stenoses, and soft plaques were present. 
It is important to determine whether angina in patients with aortic stenosis is due to the valve lesion 
or to coexisting CAD. They can be treated simultaneously by combining aortic valve replacement 
with coronary artery bypass grafting (74, 140). 
7.1.1 Calcium scoring 
Calcium screening with CT is the most sensitive and noninvasive modality to detect coronary 
atherosclerosis. 
Calcified deposits within the coronary arteries have been shown to be an independent predictor of 
CAD.  Finding no coronary calcifications would exclude the severe CAD with a high probability; 
however, with the advent of contrast-enhanced CT of coronary arteries, noncalcified vessel lesions 
and other stages of the disease, reflected by e.g. lipid-rich plaques, become visible (12).  
The conventional method of quantifying the extent of coronary artery calcification, introduced by 
Agatston and Janowitch (5), is limited by the lack of a physical gold standard by which to determine 
the accuracy and precision of coronary artery calcium measurements. Various approaches, includ-
ing coronary artery calcium area, volume, and mass, have been explored in an effort to improve the 
accuracy, precision, and portability of coronary artery calcification measures. There is considerable 
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agreement that calcium mass is the most accurate method. We used both methods to calculate total 
calcium score for each patient. Most of our patients had advanced CAD or combined CAD and se-
vere AS and therefore had fairly high calcium scores (range 0-7000) (Studies III and IV). 
According to the most recent guidelines of AHA, the quantity of coronary calcium is related to the 
likelihood of significant CAD (192). Calcified plaques are probably the result of repetitive plaque 
rupture and healing, causing shrinkage of the vessel lumen with subsequent stenosis (132). Alterna-
tively, in the presence of vessel wall calcifications, blood turbulence leads to shear stress and a 
higher probability of soft plaque ruptures (37).  
7.1.2 Plaque imaging 
CT angiography is a promising tool for a noninvasive detection and characterization of advanced 
types of atherosclerotic coronary lesions with or without calcifications (14). Examining coronary 
artery plaques by contrast-enhanced MDCT offers the possibility of noninvasively detecting com-
plex plaque morphology and of detecting earlier stages of coronary atherosclerosis (132).  
CT angiography allows to further differentiate components of coronary atherosclerosis, such as 
thrombus, lipids, and fibrous and calcified lesions (90, 91, 108, 185). The density of these noncalci-
fied lesions has been reported to be between 0 and 130 HU according to the content of lipid and 
fibrotic tissue, as revealed by histopathology or intravascular ultrasound. Noncalcified plaques with 
densities below 50 HU contain higher amounts of lipids, whereas fibrotic lesions typically have 
densities between 50 and 130 HU (132).  We differentiated calcified, fibrotic, and lipid-containing 
lesions causing narrowing or significant stenoses in coronary arteries. In Study IV, we found 13 soft 
plaques with densities varying from 0 to 124 HU. Some of these were not detected or considered as 
stenotic lesions in CCA.  
In a meta-analysis, 68% of patients that experiencing a myocardial infarction were demonstrated not 
to have any significant stenoses in their coronary angiograms within the last six months. Only 18% 
had significant stenoses and the remaining 14 % high-grade stenoses (>70 diameter reduction) prior 
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to their cardiac event. This indicates that before the event vulnerable plaques need to be present 
(180).  
The gold standard for the assessment of coronary atherosclerosis is intravascular ultrasound. How-
ever, this method is highly invasive and not suitable for the investigations of asymptomatic patients 
(108, 132). Evaluation of plaque morphology would be therefore one benefit offered by MDCT 
because earlier stages of atherosclerosis without calcifications can contain these vulnerable plaques 
that may rupture, thrombose, and cause sudden cardiac events, such as unheralded myocardial in-
farction or death (132).  
7.1.3 Evaluation of stenoses 
Conventional invasive coronary angiography is the clinical gold standard for detecting  coronary 
artery stenoses. However, the small risk of serious events, discomfort for the patient, and hospitali-
zation have prompted the search for noninvasive methods. MDCT is a promising noninvasive tech-
nique for detecting obstructive epicardial CAD.  
In our study, of patients with known CAD or AS, MDCT as compared with CCA yielded a sensitiv-
ity of 82% and 63%, a specificity of 94% and 96%, a positive predictive value 83% and 52%, and a 
negative predictive value 89% and 98% (Studies III and IV). Respectively, in other studies, sensi-
tivity of 68-93%, specificity of 89-99%, positive predictive value of 66-84%, and negative predic-
tive value of 89-98 % have been reported (49, 89, 90, 92, 93, 130, 131, 156). A sensitivity of 90% 
and specificity of 99% was found when evaluated with eight-slice MDCT-CA (116). 
The newest 64-slice CT scanners have a shorter scan times and a higher spatial resolution but also a 
higher temporal resolution compared with previous scanner generations. Significant coronary 
stenoses can be detected with the latest 64-slice CT scanner with a sensitivity of 94-99% and a 
specificity of 95-97%, positive predictive value of 76-97%, and negative predictive value of 92-
99% compared with CCA (43, 109, 122). 
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Several factors are known to impair image quality and interpretation, with severe calcifications and 
higher heart rates at the top of the list. Patients with advanced CAD frequently have more coronary 
calcium than patients in whom MDCT is used as a first-line test. As in our study, this renders 
MDCT imaging of the coronary arteries of patients with advanced stages of CAD more difficult 
(98). 
Massive calcium depositions 
Assessment of lumen in the presence of massive calcium impaired diagnostic quality because the 
lumen compromise could not be sufficiently visualized. Calcifications are high-density structures 
causing beam-hardening artifacts and partial volume effects on computed tomography (120). We 
had fairly high calcium scores for most patients, making correct analysis more difficult or even in-
hibiting evaluation of these segments. Over 61% of our patients had score over 300. Calcium score 
under 300 has been assumed to be suitable for MDCT (89, 90).  In our study, arteries with calcium 
score over 1000 were classified nonassessable. However, Kitamura and colleagues concluded that 
coronary artery calcification and calcium score determined by MDCT were associated with coro-
nary arteries with severe stenosis (82).  
Heart rates 
Artifacts due to elevated heart rates were the main cause of degraded image quality, found to inhibit 
correct analysis in several other studies (49, 98, 170). A maximum of heart rate of 63-65 beats per 
minute has been suggested by some authors (90, 92, 98, 170). Heart rates of over 65 beats per min-
ute yielded unsatisfactory results also in our study. Despite the finding that proximal vessel seg-
ments were visualizable in almost all patients, lowering of the patient heart rates below 65 beats per 
minute before undergoing MDCT-CA is advisable to achieve the best image quality (90, 170). In 
our study, β-blocker was used routinely when heart rate was over 65 beats per minute, but despite 
adequate medication, heart rates of nine patients exceeded this cut-off value (Study IV). 
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We also found that a large range in heart rate alteration affected image quality. This is consistent 
with the evaluations of Maruyama et al. with eight-slice MDCT (116).  
Cardiac motion 
Many coronary arteries were nonassessable because of cardiac motion artefacts. The middle part of 
RCA and the distal parts of LCX are the most vulnerable to motion, which results in discontinuity 
between consecutive slices. Optimal positioning of the image reconstruction window seems to be 
crucial in achieving optimal image quality. Each of the coronary arteries is known to have a differ-
ent motion pattern during the cardiac cycle (49). In our studies, images of the RCA were most fre-
quently of sufficient quality earlier in the cardiac cycle than those of LAD and LCX arteries.  
Adjacent structures, small vessel size, and non-cardiac motion 
Other reasons for degraded image quality include noncardiac motion artifacts (116). Two studies 
have reported that blending with overlying vessels led to false-positive interpretations (116, 130). In 
Study IV, a vessel diameter of under 1.8 mm was unassessable.  Vessels smaller than 1.6 mm in 
diameter could not be properly judged with any visualization technique Vogl et al. (195). However, 
this is not of particular significance when only significant stenoses are being evaluated since smaller 
segments are rarely considered for revascularization (90, 131, 170). 
Limitation of eight-row MDCT has earlier been documented to be low visibility of LCX, which is 
in accord with our findings. In our evaluation, high heart rate as well as heart rate alteration, adja-
cent structures, and small vessel diameter caused nonassessable segments mainly in LCX. RCA was 






7.2 Assessment of global and regional LV function  
 
In patients with ischemic heart disease, one of the most important determinants of long term sur-
vival is the level of left ventricle (LV) dysfunction. It is important to recognize, however, that not 
all dysfunction of the LV is irreversible and presents with an infarction. LV function can improve 
following revascularization procedures, such as percutaneous coronary angioplasty (PTCA) and 
coronary artery bypass grafting (CABG) (79). The cine MRI  is capable of visualizing abnormalities 
into global and regional wall motion and systolic thickening of the LV with a excellent of spatial 
and temporal resolution.  However, except for high-grade coronary artery stenosis, abnormalities 
can for the most part only be identified only under stress conditions.  
The purpose of Study I was to evaluate the effect of transmyocardial laser revacularization (TMLR) 
on global function, left ventricular (LV) wall thickness, and systolic wall thickening with cine MRI 
and on myocardial perfusion with thallium myocardial perfusion SPECT.  
Ejection fraction (EF) is the most commonly used parameter of systolic function in clinical practice. 
However, it is a measure of  LV performance and does not take into consideration regional contrac-
tile dysfunction, as is frequently seen with ischemic disease and primary myocardial disease (33). 
Myocardial wall thickening is useful measurement for regional function. In Study I, we evaluated 
both EF and mean diastolic thickness and wall thickening of the myocardium. No significant im-
provement was observed in ejection fraction after TMLR. We used a combination of segmental 
perfusion and wall thickening analysis to establish that laser treatment preserved systolic wall 
thickening in segments with reversible and fixed defects. While TMLR did not improve LV func-
tion, the procedure prevented worsening of wall motion in ischemic or scarred areas. Several obser-
vations have been made in animal models of ischemia that laser treatment improves LV  systolic 
and diastolic function evaluated with MRI (32, 125, 126). Laham et al. have reported on the use of 
MRI to investigate the TMLR effect of the Holmium YAG laser. In this small (n=15), open-label 
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study, the authors reported significantly improved target wall thickening and wall motion at 30 days 
and 6 months, but no improvement was seen with SPECT imaging. The authors observed that MRI 
may be a promising modality for the demonstration of a true revascularization effect (102). In most 
patient studies, the improvement of LV function has not been as obvious, which is in agreement 
with our findings. Two research groups did not observe any changes in global or regional ventricu-
lar function after TMLR in regional wall motion analysis evaluated with dobutamine echocardi-
ography (4, 27). A decrease in LV of left ventricular ejection fraction and an increase in LV end-
diastolic volume were detected with radionuclide ventriculography,  SPECT, and MRI (2).  
In Study III, cine MRI was used to evaluate regional LV wall motion. The assessment of regional 
LV function with cine MRI requires a standardized section positioning. Imaging of the central three 
of five selective short-axis sections positioned between the mitral valve annulus and the apex in 
systolic long-axis views leads to accurate and reproducible basal, midcavity, and apical short-axis 
sections. 
There was a good reproducibility of the selected intersection gap (r=0.89, p<0.001) measured mid-
cavity section with end-diastolic diameters in the vertical  (r=0.83, p<0.001) and horizontal (r=0.85, 
p<0.001) long-axis orientations (118). 
 First-pass and late enhancement studies were done simultaneously. Segments supplied by the dif-
ferent main coronary arteries were graded as normokinesia or dysfunction. We found that calcifica-
tions and significant stenoses in the main coronary arteries caused LV wall dysfunction at rest in 
50% of corresponding sectors. If the main coronary artery had both calcifications and significant 
stenosis, LV motion dysfunction was detected in up to 60% of sectors assigned to this artery. On the 
other hand, LV wall dysfunction was also found in 30% of sectors supplying for not significantly 
stenosed coronary artery. This indicates that not all dysfunction of the LV presents significant 
stenosis or calcifications in the corresponding main coronary arteries. Stenoses below 50%, soft 
plaques, and dominance of the main coronary arteries significantly affect myocardial kinetics.  By 
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combining contrast- enhanced MRI with cine studies, we are able to get even more information 
about viability and can differentiate hibernating myocardium from persistently nonviable myocar-
dium. 
 
7.3 MR first-pass studies 
 
Clinical studies suggest that magnetic resonance first-pass perfusion imaging is comparable with 
current diagnostic tests currently used clinically for the assessment of myocardial perfusion (194). 
In the cascade of myocardial events during progression of ischemia, subendocardial perfusion de-
fects are probably the earliest-documented defects, followed by transmural perfusion defects. Ide-
ally, the perfusion study should be performed both at rest and under pharmacological stress. Wall 
motion abnormalities are a later feature, eventually presenting as diastolic and systolic dysfunction 
(147). Myocardial perfusion measurements can be combined with an evaluation of global function 
and regional wall thickening (194). 
In Study III, we studied stress-induced myocardial contrast enhancement at first-pass. Calcifications 
resulted in perfusion defect in 71 % and significant stenoses in 78% of sectors assigned to these 
arteries. We used only stress first-pass imaging, which may show regions of artifactually low signal 
intensity. These could have been avoided by comparing results with rest first-pass studies. We 
evaluated perfusion defects by visual estimation. Qualitative image interpretation requires an ex-
perienced reader and may be subject to observer bias. Most previous studies have been done by 
assessing first-pass enhancement slope or myocardial perfusion reserve semiquantitatively or quan-
titatively. Nevertheless, we combined regional wall motion analysis and delayed enhancement with 
stress induced first-pass imaging, which increases specificity. 
Reduction of myocardial perfusion is a sensitive indicator of myocardial ischemia because myocar-
dial blood flow is directly correlated to myocardial oxygen supply. One group found that myocar-
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dial perfusion reserve after dipyridamole infusion resulted in highly significant differences between 
myocardial segments supplied by stenotic coronary arteries and nonstenotic arteries. They con-
cluded that MR perfusion imaging can be used to detect coronary artery stenosis with diagnostic 
accuracy (6). Based on reports by other investigators, myocardial perfusion on MR first-pass im-
ages suggests preserved or only reduced perfusion in regions supplied by competitive collateral 
vessels or retrograde filling of coronary vessels with subtotal occlusion. In these collateral-
dependent myocardial regions and in healed infarctions, nuclear tests often suggest fixed defect, 
whereas MR first-pass is able to detect the preserved blood flow supplied by collateral vessels (193, 
194). In addition, perfusion imaging demonstrates the effectiveness of coronary interventions (7). 
Lauerma et al. reported an increase of the maximal intensity slope in a group of 11 patients with 
proximal single-vessel stenosis of left anterior descending artery three months after PTCA or surgi-
cal revascularization (107). This result is in is agreement with that of Manning et al. Myocardial 
perfusion reserve (MPR) index in ischemic segments improved significantly after successful angio-
plasty but did not normalize when compared with nonischemic control segments of patients with 
single-vessel disease (115). 
Delayed hyperenhancement of dysfunctional myocardium may be used to predict lack of mechani-
cal improvement or nonviability, whereas a lack of hyperenhancement can be correlated with im-
provement of regional contractility or viability after revascularization. Hypoenhancement during 
first-pass did not serve as a reliable criterion of viability (163). One study reported, that compared 
with lack of early hypoenhancement, lack of delayed hyperenhancement had better diagnostic accu-
racy in predicting functional improvement in dysfunctional segments. Early hypoenhanced regions, 
which represent only the fraction of infarcted tissue with concomitant microvascular obstruction, 
greatly underestimate the amount of irreversibly injured myocardium (47).  
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In these two studies, first-pass contrast enhancement was not studied under pharmacological stress, 
which can more reliably identify reversible injury in the myocardium.  The contrast enhancement 
pattern after acute MI is, however, different from that of chronic MI (47, 163) 
. 
7.4 Myocardial viability 
7.4.1 Assessment of myocardial perfusion with SPECT and MRI 
The ability to differentiate between viable and nonviable myocardium plays a critical role in the 
prognosis of patients with CAD. Until recently, myocardial perfusion SPECT, which we used in the 
first study, and PET were the primary tools for this evaluation. In the last few years, however, MRI 
has made a dramatic appearance in this arena with the introduction and rapid acceptance of the de-
layed enhancement. 
Findings of several studies have confirmed a sensitivity and specificity of stress perfusion MR im-
aging equivalent or superior to those of SPECT. In the literature, sensitivity and specificity values 
of MR imaging range 64%-92% and 71%-100%, respectively (77, 161, 194). 
 
Results of myocardial delayed enhancement correlate well with those of dobutamine stress echocar-
diography (197), and there is excellent agreement with PET as well. Delayed enhancement corre-
lates with areas of decreased flow and metabolism in PET (84). MRI is, however, slightly more sen-
sitive, and a further advantage lies in MRI is its ability to visualize small, subendocardial areas of 
infarction that may be missed by nuclear techniques (33).  
In Study I, the thinned myocardium detected with MRI correlated well with fixed perfusion defects 
seen in myocardial perfusion SPECT. The hypothesis that a thinned and akinetic myocardium 
represents a chronic scar has earlier been tested by comparing MRI findings with those obtained by 
PET and SPECT in the same myocardial regions. The comparison of MR images with scintigraphic 
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images is easily accomplished; because both techniques are three-dimensional, identical regions can 
be matched (174). 
We found that TMLR prevented the change from a reversible perfusion defect to a scar, but the ef-
fect of TMLR on myocardial perfusion has been inconsistent, with improved perfusion reported in 
some studies (2, 44, 67, 68, 119, 167) and no change in the others (1, 4, 34, 134, 166). 
7.4.2 MRI and delayed enhancement studies 
SPECT is the most commonly available clinical method for assessing cardiac perfusion, although 
MRI has nowadays become a serious competitor of current clinical methods in the evaluation of 
myocardial perfusion (174). 
In Study III, we evaluated myocardial viability with contrast-enhanced MRI. Of myocardial sectors, 
57% had an infarction scar in the area related to calcifications and 56% in that related to significant 
stenoses. If the main coronary artery had both calcifications and a significant stenosis, infarction(s) 
were detected in 60 % of corresponding sectors. This is of particular significance, since significant 
stenoses affect myocardial viability, but additionally, in the presence of vessel wall calcifications, 
blood turbulence can lead to shear stress and a higher probability of plaque ruptures (37). In our 
study, infarction was also seen in 50% of sectors supplying to not significantly stenosed main coro-
nary arteries.  It has been suggested that only 30% of myocardial infarctions arise from significant 
stenoses. Soft plaques, which are often missed in CCA, may rupture and thrombose (132). Embo-
lism can cause perfusion and functional changes in the myocardial sectors as well. This may partly 
explain our findings in sectors assigned to not significantly stenosed main coronary arteries. 
 
Delayed myocardial hyperenhancement after injection of contrast material has been shown to de-
lineate areas of myocardial infarction in several human and animal studies (42, 80, 81, 106, 143, 
149, 151, 163). However, experimental and clinical studies contradict the theory that an enhanced 
myocardium invariably represents a nonviable myocardium. 
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Within the infarct zone exhibiting delayed hyperenhancement, central areas of microvascular ob-
struction (the no-reflow or low-reflow region of infarct) exhibit decreased first-pass perfusion (78, 
111). Thus, the infarct zone is not always histologically homogeneous and may contain dead or dy-
ing myocardium. Wu et al. reported that a group with hypoenhanced regions within infarct center, 
which were presumed to represent microvascular obstruction, had significantly more frequent car-
diovascular complications associated with fibrous scar formation and LV remodeling (196). 
One study with rats showed that delayed hyperenhanced zone includes a peripheral zone of poten-
tially salvageable myocardium (158), which contradicts a report by Kim and co-workers, who did 
not detect such peripheral zone (81). On the other hand, Rogers and colleagues found that hyperen-
hanced regions observed one week after reperfused infarction partially recovered contractile func-
tion by seven weeks. They described a subgroup of 13 patients in whom segments with normal con-
trast-enhanced first-pass signal and hyperenhanced signal on delayed images had partially reversi-
ble dysfunction, and thus representing predominantly viable myocardium (155). Only one such 
segment was found in an other study (163). However, both studies had many segments with absence 
of normal first-pass enhancement and delayed hyperenhancement. The first group concluded that 
these latter segments show borderline improvement and likely contain an admixture of viable and 
necrotic myocardium. The second team concluded that most (24/25) segments with delayed hyper-
enhancement are nonviable (163). 
Currents techniques have the spatial resolution to show transmural differentiation of late enhance-
ment. In a direct comparison with myocardial perfusion SPECT, delayed contrast-enhanced MRI 
was superior to SPECT in detecting subendocardial infarctions (62). We found that late enhance-
ment was detected more often than LV wall dysfunction in small and subendocardial infarctions. It 
has been shown that the lower the extent of late enhancement, the higher the probability of func-
tional recovery (25, 80).  Regional wall motion improvement has been found in the majority of 
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segments with up to 50% transmural late enhancement, whereas global improvement can occur if 
the area of late enhancement is limited to less than 25% of LV wall thickness (162). 
7.4.3 Combined cardiac MRI techniques 
We used a combination of rest cine MR and delayed contrast-enhanced imaging as a reference 
method to detect remote myocardial infarctions evaluated with MCG (Study II).  
Myocardial delayed enhancement combined with cine MRI helps differentiate wall-motion abnor-
malities of myocardial stunning, which are reversible, from those of myocardial infarction, which 
are often irreversible depending on the severity of the injury. Either condition may cause a wall mo-
tion abnormality, but delayed enhancement occurs only with infarcts. Lack of delayed enhancement 
indicates stunning rather than infarction and a high likelihood that LV function will fully recover 
(190). Reversible myocardial dysfunction can be identified by contrast enhanced and cine MRI be-
fore revascularization (hibernating myocardium) (81). A few studies assessed with cine and con-
trast-enhanced MRI have shown that transmural late enhancement is associated with lack of func-
tional recovery after acute myocardial infarction (25, 162).  
 
Assessment of myocardial viability remains controversial. Results of Study III suggests combina-
tion of all three MRI methods, first-pass perfusion, regional wall motion, and delayed contrast-
enhancement analysis to evaluate myocardial recovery.  
The combination of first-pass enhancement analysis and wall motion assessment with stress signifi-
cantly increased the specificity of MR imaging in detection of unviable sectors in study by Lauerma 
et al. (106).  
Three MRI methods were used to study functional recovery of transmural infarction.  
One study concluded that the inotropic reserve was confined to a dysfunctional myocardium with 
normal contrast enhancement but not with early hypoenhancement. The inotropic response in the 
delayed hyperenhanced myocardium was influenced by transmurality of necrosis. These observa-
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tions support the use of contrast-enhanced MRI for the clinical detection of myocardial viability 
(48). Our result in which LV wall dysfunction was detected less often than infarction is also consis-
tent with these observations, indicating that myocardium in thin, subendocardial infarctions may 
reserve contractile function. 
In the clinical study by Rogers et al, patients were examined  early after reperfused first acute MI. 
Regions with normal first-pass signal followed by hyperenhanced signal on delayed images showed 
systolic wall motion improvement 7 week later. Regions with hypoenhancement at first-pass did not 
improve, and regions with additional delayed hyperenhancement only tended to improve (97, 155). 
One possible reason for these deviant results is significant differences in contrast enhancement of 
the infracted myocardium between animal models. Studies have shown that dogs, rats, and humans 
have different levels of collateral development in response to chronic ischemia. Similarly, the ede-
matous response to ischemia/reperfusion injury may vary between species. In addition, significant 
differences are present in the MR pulse sequences used in various studies (137). A close correlation 
between late enhancement and necrosis was found in canines, whereas an overestimation of infarct 
size by Gd-DTPA was demonstrated in rats. In humans, the extent of enhancement possibly may 
depend on both the time-point after MI and the time-point after injection, since myocardial edema 
probably contributes to contrast enhancement in acute/subacute MI (162). 
 
7.5 Combined information from MDCT and MRI 
 
We combined results of two noninvasive methods MDCT and cardiac MRI, to evaluate changes 
caused by CAD (Study III).  Stenoses in the main coronary arteries found in MDCT-CA were com-
pared with MRI findings. LV wall motion dysfunction at rest, perfusion deficits in stress-induced 
first-pass studies, and late enhancement imaging corresponded variably with calcifications and sig-
nificant stenoses in the different main coronary arteries. Late enhancement was detected more often 
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than LV wall dysfunction because some infarctions were only thin and subendocardial. LV wall 
motion was not disturbed in these cases. This finding is in agreement with study by Gerber et al., 
who suggested that nontransmural infarctions present some degree of improvement (48). However, 
we observed LV wall motion dysfunction, perfusion defects, and infarctions also in sectors related 
to not significantly stenosed coronary arteries. 
Combining the results of MDCT and MRI, the following observations were made: 
Firstly, false negative findings were made with MDCT-CA. Two of the proximal RCA stenoses, 
one LAD stenosis, and two LCX stenoses were missed. Massive calcium depositions and high heart 
rates resulted in misinterpretations in these cases. 
Secondly, in five patients deviant dominance of the main coronary arteries was present. When a 
stenosed coronary artery was assessed as dominant LV wall dysfunction, perfusion defect, and in-
farction was observed in the adjacent myocardial sectors. This reveals that myocardial sectors 
should be divided according to dominance of the main coronary arteries. In our study, sectors 1 and 
6 were assigned to LAD, sectors 2 and 3 to LCX and sectors 4 and 5 to RCA territories. Coronary 
artery territories have earlier established in nuclear and MRI studies (6, 29). DePasquale et al. as-
signed sectors 1, 6, and partly 2 and 5 LAD, 2 and 3 to LCX, and 4 and 5 to RCA. In an MRI study, 
sectors 1 and 6 were assigned to LAD, sector 3 was assigned to LCX, and sector 5 was always as-
signed to RCA. Segment 2 was assigned to either LAD or the LCX (depening on the angiographic 
appearance). Segment 4 was assigned in the same manner to either LCX or to the RCA (6). 
Thirdly, stenoses of  less than 50% and stenoses in side branches not evaluated with MDCT-CA but 
detected in CCA caused changes in myocardial perfusion and LV kinetics in our patients. This is in 
concordance with the finding that approximately 90% of acute myocardial infarctions arise from 
nonrelevant lesions (132).  
Fourthly, despite some arteries being classified as normal in CCA and MDCT, we observed signs of 
dysfunction and ischemia in the corresponding myocardial sectors. Misinterpretations of MRI can 
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be one reason. Clinically established and the most commonly available techniques for the assess-
ment of viability are dobutamine stress echocardiography, SPECT, and PET with a sensitivity range 
of 81-90% and a specificity range of 47-81% (162). MRI is a good technique and offers a sensitivity 
of 79-83% and a specificity of 88-93% (84, 106). It′s findings correlate well with above-mentioned 
methods, but visual interpretation is highly dependent on the reader’s experience.  
We used a fairly low dose of contrast media compared with the larger doses (0.1-0.3 mmol/kg) re-
ported in several late enhancement imaging studies (47, 80, 81, 84, 149). In perfusion studies, lower 
amounts of contrast media (0.025-0.05 mmol/kg) have been applied (7, 106). Despite the relatively 
low dosage of contrast material used here, we could delineate infarctions quite well in late en-
hancement pictures.  In addition to the amount of contrast media, delay for late enhancement and 
determination of correct inversion time are critical for good diagnostic images.  
Our findings suggest that combining information from MDCT-CA and functional MRI is beneficial. 
However, further clinical investigation is needed to define the technical requirements for optimal 
imaging, to develop accurate quantitative image analysis techniques, to outline criteria for image 
interpretation, and define the clinical indications for both MR and CT imaging. 
Limitation of our studies was that we had a low number of patients. We did not evaluate intraob-




In addition to exercise ECG, several other methods, including the radionuclide techniques, MRI, 
and stress echocardiography, are daily practise in ischemia detection. All of these methods have, 
however, disadvantages, and the development of the new techniques to evaluate more accurately the 
extent and localization of the ischemic myocardial area is still warranted. 
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MCG is a noninvasive and non-contact mapping technique for studying the electromagnetic func-
tion of the heart (182). The MCG records the magnetic field induced by the same bioelectric cur-
rents that generate the ECG. In addition to the morphological features of the MCG, such as the 
QRS-complex and the ST-segment, the spatial distribution of the multichannel MCG signal pro-
vides information on the cardiac cavity (157). 
MCG is most sensitive to currents that are tangential to the chest but it can also detect circular vor-
tex currents that give no ECG signal (157). 
Recent studies on exercise MCG have demonstrated its potential to detect transient ischemia. In 
CAD, ischemia induces changes in the magnetocardiographic QT dispersion (58) and orientation of 
magnetic field maps (71, 183). MCG has also been used to localize transient and chronic ischemia 
(72).  
In the Study II, we evaluated the electrophysiological abnormalities produced by remote MI in 
MCG mapping and applied cine- and contrast-enhanced MRI as a reference method. Our results 
showed that several magnetocardiographic repolarization indexes could distinquish patients with 
remote myocardial infarction from controls. These repolarization abnormalities were more distinct 
in patients with Q-wave MI than in patients with non-Q-wave MI. In the former group the indices 
may perform as well as the conventional ECG QRS criteria in detection of healed MI. In patients 
with non-Q-wave MI, a trend similar to that in with Q-wave MI was found, but the abnormalities 
were less distinct. The relation of QRS area to ST-segment, T-wave, and STT-wave integrals im-
proved the detection of remote MI. When comparing the MI patients with the controls, the orienta-
tion of the magnetic field differed more in the STT-wave maps than in the QRS maps. In accor-
dance with our results, earlier MI studies have also suggested that in post-MI patients MCG may 
show information complementary to the ECG especially during the repolarization phase (105). Van 
Leeuwen et al. have shown that post-MI patients demonstrate different patterns of spatial QT-time 
distributions than healthy subjects (188). Kandori et al. have also found abnormalities in the MCG 
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signal during ST segment in patients with CAD with or without previous MI (75). In addition, cur-
rent density reconstruction maps have shown ST-segment repolarization abnormalities in patients 
with CAD but unimpaired LV function (57) 
The optimal recording sites for the QRS and STT-wave indexes did not show extensive variation in 
between the MI groups, in consistent with our earlier studies on exercise-induced transient ischemia 
(71). 
QRS-ST, QRS-T, and QRS-STT discordance could separate the MI group and the QMI subgroup 
from the controls, with the AUCs between 70% and 80%. QRS-STT discordance has earlier been 
applied in detection of LV hypertrophy (76). In our study, the performance of the QRS-STT discor-
dance was dependent on the extent of the known MI damage, with better discriminative power in 
the QMI subgroup, with exhibited lower LV systolic function and thus more extensive MI damage 
than the NQMI subgroup. 
The MFM orientation is especially sensitive in reflecting the spatial changes over the MCG map-
ping area, even when the sums of the indexes fail to demonstrate any difference. The present study 
showed that, although the sums of the STT-wave indexes did not separate the MI groups from the 
controls, the STT angle did distinguish the MI group and the QMI subgroup from the controls. In 
addition, the QRS-STT angle was larger in the QMI subgroup than in the controls, whereas for the 
NQMI group, in spite of the similar trend, the difference was not significant.  
Earlier studies have shown that the MFM orientation changes during exercise-induced myocardial 
ischemia both in patients with single- and multivessel disease (71, 72). Furthermore, a recent study 
has also shown that the QRS-STT angle is larger in patients with LV hypertrophy than in healthy 
controls (76). 
The MCG repolarization variables are reliable in detecting remote MI and may perform as well as 
the conventional electrocardiographic QRS criteria in detecting healed MI. These STT-wave ab-
normalities are more pronounced in patients with Q-wave MI than in patients with non-Q-wave 
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MI. Relating the signals of depolarization and repolarization phases improves the detection of 
remote MI. Repolarization abnormalities are common in remote MI and thus should not always 






I) In severe, progressing CAD TMLR does not improve global LV function or myocardial perfu-
sion, but it does preserve systolic wall thickening in fixed defects (scar). It also prevents changes 
from ischemic myocardial regions to scar.  
II) The MCG repolarization variables are informative in remote MI, and may perform as well as the 
conventional QRS criteria in detection of healed MI. These STT abnormalities are more pronounced 
in patients with Q-wave MI than in patients with non-Q-wave MIs. Combining the signals of depo-
larization and repolarization phases improves the detection of remote MI compared with either of  
these signals alone. Repolarization abnormalities are common in remote MI and thus should not 
always be interpreted as acute ischemia. Clinically established techniques for assessment of viabil-
ity are low-dose dobutamine stress echocardiography and myocardial perfusion SPECT, but MRI 
can be reliably be used as a reference method.   
III) Noninvasive eight-row retrospectively ECG-gated MDCT is a good tool for detecting coronary 
artery stenoses. CCA and MDCT-CA yielded similar results in evaluating stenotic lesions above 
50% in the main subepicardial coronary branches. Combining the data from MDCT-CA and MRI 
revealed the variability of myocardial response to calcifications and high-grade stenoses in the main 
coronary arteries. 
IV) Our study showed a low sensitivity (sensitivity 63%) in detecting obstructive CAD in patients 
with severe aortic stenosis. Compared with CCA MDCT offers superior of visualizing soft plaques 
and measuring calcium burden of the coronary tree. However, massive calcifications and motion 
artifacts, especially in the right coronary artery, can complicate correct assessment of the lumen of 
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